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ABSTRACT
This study investigated the effects of participation and self-efficacy on six-month outcome
from inpatient Minnesota model chemical dependence treatment. The goal was to
determine the extent to which effects on outcome that could be attributed to participation
in treatment were mediated by self-efficacy. Covariance structure analyses showed that
self-efficacy predicted relapse latency at the six-month follow-up, converging with similar
findings from smoking cessation research. A supplementary model including both general
participation and a more specific topic group dose measure showed that these factors
produced significant but competing effects on self-efficacy, with opposing indirect effects
on relapse latency that were completely mediated by self-efficacy. These results support
the use of self-efficacy as a common metric for examining treatment effects.

lX

CHAPTER 1
INTRODUCTION
Alcoholism treatment programs based on Minnesota model chemical dependence
(MMCD) principles, still the dominant treatment modality in the United States today at
the practice level (Kahle & White, 1991 ), postulate that alcoholism is a disease whose only
legitimate treatment goal is abstinence (IOM, 1990). For this reason, MMCD treatment
places its primary emphasis on instilling beliefs and skills that will facilitate and maintain
abstinence. The goal ofMMCD treatment can be seen as an attempt to inculcate both
positive and negative outcome expectations regarding alcohol use: life-long abstinence
from alcohol is stressed as the only "cure," and attention is directed to the belief that a
return to drinking at any level will precipitate full-blown relapse. At the same time, both
positive and negative efficacy expectations are also instilled: the individual must be
convinced that mastery over drinking impulses can be attained, yet he or she must
additionally accept the fact of powerlessness and inability to cope when faced with alcohol
(Rollnick & Heather, 1982). In MMCD programs, these changes in expectations are
accomplished by breaking down "denial," by providing a new normative reference group
consisting of other recovering individuals, and by precipitating a "conversion experience"
to a new belief system in which abstinence is paramount (Cook, l 988a).
Apart from a general lack of controlled studies of MMCD outcome (Cook, l 988b;
Miller & Hester, 1986), three key problems plague MMCD research. The first of these is
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the difficulty of operationalizing core constructs such as surrender of personal control to a
"higher power," denial, or the conversion experience believed to be central to treatment
success (Cook, 1988a; Marlatt, 1985; Miller, 1985; Miller & Rollnick, 1991;
Morgenstern, Frey, McCrady, Labouvie, & Neighbors, 1996; Morgenstern & Mccrady,
1992; Room, 1993). This situation has lead to attempts to frame MMCD processes in the
language of expectations (cf., Rollnick & Heather, 1982, above), but this carries problems
of its own. The expectancy construct has a venerable tradition in psychological research
(Bandura, 1986; Bolles, 1975; Fishbein & Ajzen, 1975; MacCorquodale & Meehl, 1954;
Maier & Seligman, 1976; Osgood, 1950; Rotter, 1954; 1966; Tolman, 1932), and has
been widely used in studies of the etiology, maintenance and treatment of addiction
(Stacy, Widaman & Marlatt, 1990). As a result, controversies in this area abound, ranging
from the question of alcohol versus abstinence expectations, to debates about additive
versus multiplicative combinations in expectancy-value models, or the factor structure of
expectancy scales versus cluster models and spreading activation (Brown, 1985; Goldman,
1994; Leigh, 1989; Solomon & Annis, 1989; Young & Oei, 1993). Consequently, there
appears to be no widely accepted set of expectancy measures upon which to base a
comprehensive analysis of MMCD treatment processes.
This is compounded by a second problem, the question of motivation. The current
view in addictions research seems to be that the utility of the confrontational approach
employed in MMCD programs is mediated by patient motivation and compliance with
treatment recommendations (Brownell, Marlatt, Lichtenstein & Wilson, 1986; IOM,
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1990). In fact, motivation is widely believed by those from varying theoretical perspectives
to be a key factor in recovery from alcohol-related problems, constituting one of the few
consistent predictors of alcoholism treatment outcome (Fawcett, Clark, & Aagesen, 1987;
Finney, Moos, & Chan, 1981; Fuller, Branchey, & Brightwell, 1986; Westermeyer &
Neider, 1984). As Miller's (1985) cogent review of the subject points out, however,
motivation has also been operationalized in various ways, including agreement with
therapist, acquiescence to the sick role, expressed desire for help, subjective distress,
compliant attitude, and apparent willingness to trust the therapist's judgment. An
individual's stated willingness or intention to participate in treatment has been found to be
unrelated to actual participation or outcome, and while therapist perceptions have been
related to compliance with treatment and outcome, this could well be due to the selffulfilling nature of therapist expectancies. Miller also notes that the typical trait-based
approach to motivation tends to discourage intervention because it attributes motivation
to stable internal sources.
A third problem surrounding MMCD research is closely related to the two
previous issues. This is the use of"black box" evaluation designs, focusing primarily on
the treatment program taken as a whole, or upon differences in comparison with other
treatment modalities, rather than upon treatment processes and components (Moos,
Finney, & Cronkite, 1990; Morgenstern & McCrady, 1992). By taking steps like assessing
the motivational level and degree of participation of patients, process factors like these
could be controlled in the examination of post-treatment drinking behavior and we could
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determine whether or not this level of specificity enhances the prediction of outcome
(Chen & Rossi, 1983). Yet attempts to incorporate process in MMCD evaluations are
most often limited to specification of program setting or length of stay, and it is typically
assumed that all patients within a program receive the same treatment. Research shows
that this is not the case. Treatment experiences differ according to opportunities for choice
(Kissen, Platz & Su, 1971 ), level of alcohol dependence and pattern of use (Simpson &
Sells, 1983), pre-treatment history (Billings & Moos, 1984), and pre-existing expectations
(Davies, 1981). Patients in the same programs, in varying degrees of withdrawal and
recovery, selectively attend to different services (Becker & Jaffe, 1984), function at
different levels early and late in treatment (Cernovsky, 1984), and get different amounts of
staff attention and program resources (Berman, Meyer & Coates, 1984). As a result, we
cannot identify the strength or integrity of treatment provided to the individual patient,
much less the reasons for, or the effects of, this type of self-selectivity or differential
component delivery (Moos, Finney & Cronkite, 1990). Process analysis is of particular
importance in evaluating MMCD programs, since the long-term goal of abstinence, usually
measured as the primary outcome criterion in evaluation studies, depends on the shortterm goal of inculcating beliefs and converting the patient. Since this intermediate process
of conversion is so hard to operationalize and is so closely related to the sticky question of
motivation, it has been neglected in the design ofMMCD research. As a result, a critical
gap exists in this literature.
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Calls to focus on these issues have led to significant progress in addressing
methodological problems (Longabaugh, 1989), and recent attempts to identify the key
components of various schools of treatment are also encouraging (e.g., McLellan,
Alterman, Cacciola, Metzger & O'Brien, 1992; Moos, Finney & Cronkite, 1990;
Morgenstern & McCrady, 1992). The problem with applying that strategy in this case is
that MMCD treatment is intended as a multi-component approach, designed to
incorporate promising elements drawn from various sources (IOM, 1990). Survey
research confirms that this is the case among practitioners who espouse disease model
tenets (McCrady, 1994), and it suggests that the MMCD model is "becoming a more
complex treatment approach integrating the therapeutic aspects of other models"
(Morgenstern & McCrady, 1992). This eclecticism has received post-hoc justification in
light of recent evidence that common stages of change can be identified across addictive
behaviors, and that different processes are utilized to best advantage by those at different
stages (Prochaska & DiClemente, 1983). Those in contemplation or precontemplation
stages, for example, may get the most benefit from a motivational intervention, which aids
them in moving to the next stage, whereas those who have already progressed to the
action or maintenance phase may be the ones who profit most from behavioral techniques
and skills training (Prochaska, DiClemente & Norcross, 1992).
One promising avenue for MMCD research might be to view this type of treatment
as an amalgam of motivational interventions (e.g., persuasion and modeling) and skills
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training (performance) in the context of self-efficacy enhancement. Bandura introduced
self-efficacy
... based on the principal assumption that psychological procedures,
whatever their form, serve as a means of creating and strengthening
expectations of personal efficacy .... By postulating a common mechanism
of operation, this analysis provides a conceptual framework within which
to study behavioral changes achieved by different modes of treatment
(Bandura, 1977, pp. 193 & 195)
As described by Bandura (1977; 1986), self-efficacy is considered a central
cognitive mediator of behavior, influencing behavioral choice, and determining the amount
of effort expended in performance, and persistence in the face of difficulties. Since its
introduction self-efficacy has been successfully applied in domains as diverse as sports
performance (Feltz, 1982}, vocational choice (Betz & Hackett, 1981 }, academic
performance (Bandura & Schunk, 1981 }, social skills training (Lee, 1984), and treatment
of phobias (Williams & Watson, 1985). In the past two decades, self-efficacy has become
one of the most frequently cited terms in the social, clinical and counseling psychology
literature (Maddux & Stanley, 1986).
Bandura (1977) identified four sources of self-efficacy information: performance
accomplishments, vicarious experience (live or symbolic modeling}, verbal persuasion
(including interpretation and self-instruction}, and visceral experience (e.g., emotional
arousal). Performance is thought to be the strongest source of efficacy expectations
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because it based on direct evidence of personal mastery, but each of the other sources,
albeit weaker, is still a potentially significant contributing factor. Since MMCD treatment
incorporates all four sources of efficacy information in its multi-modal package, MMCD
treatment effects and key constructs like the intermediate goal of conversion could
presumably be assessed in terms of changes in alcohol abstinence self-efficacy. This would
do precisely what Bandura intended, putting behavioral treatments for alcohol problems
and MMCD treatment in the same metric for study and comparison.
In fact self-efficacy has been widely used as a mediating concept in etiological
theories of addictive behavior, and it has a demonstrated track record of success as a
predictor of smoking cessation treatment outcome (Baer, Holt & Lichtenstein, 1986;
Condiotte & Lichtenstein, 1981; Di Clemente, 1981; DiClemente, Prochaska & Gilbertini,
1985; Velicer, DiClemente, Prochaska & Brandenburg, 1985). Unfortunately, only a few
studies could be located in which self-efficacy has been examined in relation to alcoholism
treatment (e.g., Annis & Davis, 1988; Burling, Reilly, Moltzen & Ziff, 1989; Di Clemente,
Carbonari, Montgomery & Hughes, 1994; Solomon & Annis, 1990), and in none of these
cases was the focus of research MMCD treatment.
To remedy this, and to address some of the issues outlined above, the present
study used self-efficacy in conjunction with self-reported levels of treatment participation
to examine the extent to which effects on outcome that could be attributed to participation
in MMCD treatment were mediated by self-efficacy at discharge.

CHAPTER2
COMPETING THEORETICAL PARADIGMS
This investigation involves an analysis ofMMCD treatment disease model of alcoholism -

from the perspective of self-efficacy -

which is based on a
a social learning

theory principle. The disease model and the social learning approaches have been seen by
some as competing theoretical paradigms (cf, McCrady, 1994; Morgenstern & McCrady,
1992). For this reason, a brief overview of the two perspectives will be presented.
The Disease Model
The emphasis in the disease model is on biological parameters, with a focus on the
pharmacological effects of alcohol. It is believed that for some individuals a (presumably
genetic) predisposition affects alcohol metabolism, such that consumption of alcohol
inevitably leads to increased craving and loss-of-control drinking. This is seen as a lifelong
condition, with no possibility of cure: the only solution is to maintain complete and total
abstinence. This disease is assumed to be latent in the affected individual before the first
drink is ever taken, to manifest itself in biological, psychological and social sequellae, and
to remain in existence after drinking stops, regardless of the duration of abstinence. The
disease model is usually extended to include the concept of"chemical dependence," the
belief that addiction-prone individuals are vulnerable to other mood-altering substances as
well as alcohol, but the core concept is loss of control. The disease model considers
alcoholism to be "chronic, primary, and progressive," meaning that alcohol is the focus of
8
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intervention, rather than merely a symptom of underlying problems, and that if left
unchecked, the disease will follow a deteriorating course. From the point of view of this
model, any consumption of alcohol after a period of sobriety indicates relapse (Jellinek,
1952; Laundergan, 1982; McCrady, 1994).
Since the cause of the disorder is irremediable, the main focus in treatment
programs based on this model (e.g., MMCD treatment) is promulgating this perspective
and "converting" the affected individual to the disease model point of view. Cook (I 988a)
lists four key elements of treatment: (a) attention to the possibility of change, (b) emphasis
on the disease concept, ( c) a goal of abstinence and improved lifestyle, and
( d) participation in a twelve-step program such as Alcoholics Anonymous (AA). These
elements encompass growth of a broader awareness, recognition and acceptance of choice
and responsibility, and reconstruction of relationships. In this context, the treatment
program provides opportunities to focus on change, an atmosphere conducive to and
supportive of change, and peer-group counseling, information, and professional guidance.
A Model Based on Social Leaming Principles
In recent years, the field has seen the emergence of a new model of the etiology
and treatment of alcoholism based on cognitive psychology, social learning theory, and
experimental social psychology (Marlatt, 1985). This approach uses an analysis of the
expectations, attributions, and intentions believed to constitute the addictive behavior
cycle to integrate information about relapse processes across substances.
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In this analysis, when faced with a difficult or challenging situation, the individual
must initiate a coping response. Due to the accumulation of positive outcome expectancies
for alcohol -

which result from observational learning, as well as direct experience -

the

coping mechanism selected in response to stress is most likely to be alcohol consumption.
Use of alcohol as a coping response is reinforced by its immediately gratifying effects
(e.g., drinking calms anxiety), which further strengthens positive outcome expectations for
drinking. Over time, initiation of drinking as a coping mechanism becomes a habit, an
automatic response to stressful situations. Given this scenario, attempts to change the
addictive behavior focus on bringing the habit back to the level of conscious awareness by
identifying "high risk" situations (i.e., the stressful circumstances most likely to trigger
alcohol use), and developing risk avoidance strategies and alternative coping mechanisms
designed to replace alcohol consumption (Marlatt, 1985).
Fallowing Bandura' s ( 1977) analysis of self-efficacy, Marlatt ( 1985) outlines the
events that comprise relapse to alcohol use after a period of abstinence. If the individual
initiates an alternative coping response when faced with a high-risk situation, this increases
self-efficacy to abstain from drinking, weakens positive outcome expectations for alcohol,
and decreases the probability of relapse. However, if no alternative coping response is
initiated, or if the coping response is inadequate or unsuccessful, abstinence self-efficacy
decreases and the salience of positive outcome expectations for alcohol increases. This is
likely to eventuate in a "lapse" or "slip," a retreat into an episode of drinking to cope. To
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emphasize the parallel roles of self-efficacy and positive outcome expectancies in this
model, the events constituting the relapse process are depicted schematically in Figure 1.

Figure 1
Schematic Depiction of the Relapse Process

....---------+----------.
Alternate
Coping Response

Abstinence
Self-Efficacy

Alcohol
Consumption

Positive Outcome
Expectancies for Alcohol

High Risk
Situation

'---------+----------'
Note. Adapted from "A cognitive-behavioral model of the relapse process," by G. A.
Marlatt, 1985, in Relapse prevention: Maintenance strategies in the treatment of
addictive behaviors (p. 38), G. A. Marlatt, & J. R. Gordon, Eds., 1985. NY: Guilford
Press. Copyright 1985 by Guilford Press.

Given that a lapse has occurred, a second phase begins that Marlatt (I 985) calls
the abstinence violation effect. Here, attributions about the cause of the lapse are made. If
attributed to internal factors, a negative reaction ensues from comparing immediate
behavior (lapse) with ideal behavior (abstinence). The larger the discrepancy (dissonance),
the greater are reactions of guilt and self-blame, and the greater the likelihood of either
behavioral reactance (retreating to the addictive behavior) or cognitive reactance
(redefining the self-image in line with the lapse). Either way, the probability ofrelapse
increases as a result of internal attributions about the cause of the lapse. As Rollnick and
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Heather (1982) point out, abstinence-oriented treatment stressing the uncontrollable
nature of drinking (i.e., negative alcohol abstinence self-efficacy, or the loss-of-control
tenet) may exacerbate this problem, setting the stage for a self-fulfilling prophecy.
Contrasts and Comparisons
One of the main benefits of the disease model is that it removes stigma by
absolving the alcoholic from guilt or responsibility for the condition, which allows the
person to seek help (Marlatt, 1985). The key facets of treatment are believed to have their
effect by enabling the individual to "place trust outside the realm of conscious effort" and
focus on the easier step of resisting temptation (Cook, l 988a). Self-help and mutual-aid
elements like AA attendance and social reintegration within a community of recovering
individuals serve to convert the alcoholic's social network from blame to support, which
helps increase responsibility and participation. These elements comprise a well-developed
ideology and provide a fixed community of belief, an action program, constructive activity
toward shared goals, rewards for sobriety, and the living example of individuals who have
remained sober as evidence that recovery is possible.
A central concept in social learning-based treatment, on the other hand, is the view
that beliefs about the course of events play a significant role in determining the actual
course of events. If any lapse is equivalent to failure, as taught in the disease model, the
individual is considered more likely to relinquish efforts to control drinking behavior after
a lapse has occurred and yield to what is perceived as "inevitable." By contrast, if a lapse
is framed as a chance for new learning to occur, the individual is believed to be less likely
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to abandon efforts to control behavior.
As noted by McCrady {1994), contrasts between the two paradigms are apparent.
The language is different -

the disease model focuses on a presumed disease entity,

whereas the social learning approach addresses alcoholism as a learned habit. The disease
model is based on a univariate view of the etiology of alcoholism, while in the behavioral
model the emphasis is on a variety of internal, environmental, and interpersonal
determinants of alcohol-related problems. Disease model proponents see exaggerated
beliefs about personal control as part of the problem, as compared to the social learning
approach, which tries to enhance mastery and personal control. Abstinence is considered
the only appropriate treatment goal from the disease model perspective, whereas the social
learning viewpoint focuses on a negotiated, rational choice of goals in which controlled
drinking may be considered appropriate for some individuals.
As McCrady ( 1994) points out, given these different bases (e.g., mastery and selfcontrol versus powerlessness and surrender), an integration at the level of theory seems
unlikely, but several commonalities suggest that the two paradigms can be integrated at
the level of practice. Both models place a strong emphasis on initial behavior change. Both
prescribe courses of action, emphasizing alternate behaviors and activities incompatible
with drinking. Both focus on identifying risk situations, and encourage recognition and
modification of dysfunctional cognitions. Both stress the role of negative affect in creating
high risk situations, and both emphasize the benefits of social networks that reinforce
abstinence. Given different theoretical bases but many common elements and processes, a
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strategy of matching patients to treatments personal characteristics of individuals -

coordinating treatment philosophy with the

may lead to better outcomes overall.

The social psychological relapse prevention approach outlined by Marlatt (1985)
and Annis (1986) achieves an admirable and easily-understood integration of self-efficacy
and outcome expectancy constructs, and has received a great deal of empirical support, in
terms ofboth its individual components (Baer, Holt, & Lichtenstein, 1986; Condiotte &
Lichtenstein, 1981; Curry, Marlatt, & Gordon, 1987; Di Clemente, 1986; Harackiewicz,
Sansone, Blair, Epstein, & Manderlink, 1987; Mann, Chassin, & Sher, 1987), and in terms
of the program as a whole (Annis, 1986; Cooper, Russell, & George, 1988; Velicer,
DiClemente, Rossi, & Prochaska, 1990). In contrast, outcome evaluations of treatment
programs based on the disease model have yielded equivocal results and been criticized for
methodological shortcomings by a number of authors (e.g., Cook, 1988b; Emrick &
Hansen, 1983; Holder, Longabaugh, Miller, & Rubonis, 1991; Miller & Hester, 1986;
Moos, Finney, & Cronkite, 1990). However, MMCD treatment is intended as a multicomponent approach designed to incorporate promising elements drawn from various
sources (IOM, 1990), and this includes elements of social learning theory. Recent survey
research confirms that such principles are being employed by practitioners who espouse
disease model tenets (McCrady, 1994; Morgenstern & McCrady, 1992), suggesting that
the two models are neither mutually exclusive nor necessarily incompatible. This supports
the use of social learning concepts like self-efficacy as a means of evaluating MMCD
treatment.

CHAPTER3
EMPIRICAL INVESTIGATIONS
Self-efficacy has often been studied in smoking cessation programs, but much less
frequently in the context of treatment for alcoholism and eating disorders (Di Clemente,
1986~

Stephens, Wertz, & Roffman, 1995). In fact, only a small number of studies using

self-efficacy in the context of alcoholism treatment outcome could be found. These studies
and several of the smoking investigations will be described here.
Self-Efficacy and Smoking Cessation
In one of the earliest reports applying the self-efficacy construct to smoking,
Di Clemente ( 1981) compared three different smoking cessation procedures, measuring
self-efficacy in 63 individuals one month after quitting and abstinence five months later.
None of the demographic or smoking history variables predicted abstinence at follow-up,
but self-efficacy did. There were significant correlations between self-efficacy and both
weeks of successful abstinence and self-reports of difficulty in maintaining abstinence.
Since all subjects were abstinent at the time of the self-efficacy assessment, outcome
differences were not attributable to differences in the ability to achieve abstinence.
DiClemente concluded that efficacy appeared to be highly positively related to the ability
to maintain smoking abstinence, even though the range of the efficacy measure appeared
to be restricted. Further, he suggested that his results supported the view that self-efficacy
was superior to past behavior as a predictor of subsequent abstinence rates.
15
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Condiotte and Lichtenstein ( 1981) conducted one of the most widely-cited selfefficacy studies in the addiction field. They collected self-efficacy ratings from 78
participants in two smoking cessation programs both before treatment and at the end of
treatment, along with follow-ups at five weeks, eight weeks and 12 weeks after
termination. Some subjects were also asked to monitor smoking behavior, mood states,
and self-efficacy on a daily basis during the first five weeks after treatment. These
investigators found that treatment significantly enhanced self-efficacy in both programs
and that self-efficacy continued to increase during the follow-up period. Using multiple
regression to predict abstinence status and time to first use, they were able to account for
32% of the variance in smoking status at the initial follow-up, and 48% of the variance in
time to first use. Further, they found a high degree of correspondence between the lowest
self-efficacy scores and the circumstances surrounding the first relapse to smoking. On the
basis of these results, Condiotte and Lichtenstein concluded that there was indeed a strong
inverse relationship between abstinence self-efficacy and smoking behavior at follow-up.
A large-scale study of957 smokers conducted by DiClemente et al. (1985) showed
that, as expected, smokers in earlier stages of change (i.e., contemplation or precontemplation stages) had lower levels of smoking abstinence self-efficacy, while those
who had already quit (i.e., those in the later action or maintenance stages of change)
showed higher levels of abstinence self-efficacy. Similar to the results reported by
Di Clemente ( 1981 ), efficacy was found to be superior to past performance as a predictor
of smoking behavior in this study. The investigators concluded that self-efficacy reliably
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discriminated between smoking status categories, and that it was significantly correlated
with specific activities related to cessation and maintenance.
Velicer, DiClemente, Prochaska, and Brandenburg (1985) conducted a smoking
cessation study using 116 subjects which demonstrated that scores on their pros of
smoking scale (which measured positive outcome expectancies for smoking) were high for
those in pre-contemplation, contemplation, and relapse stages of smoking change, but low
for those in the action and maintenance stages. Slightly different results were found for the
cons of smoking (negative outcome expectancies): those in pre-contemplation and
maintenance phases showed low con scores, whereas cons were highest for those in the
contemplation and action stages, a finding attributed to the lower salience of smoking cues
in general for those in the maintenance phase. More relevant here, self-efficacy was found
to be one of the best predictors of smoking outcome at six-month follow-up.
Baer, Holt, and Lichtenstein ( 1986) conducted a somewhat more methodologically
rigorous investigation of self-efficacy with 146 participants in several smoking cessation
programs. They attempted to address several questions about self-efficacy measurement,
as well as to examine competing models of self-efficacy effects. They found that the selfefficacy measure they used was primarily unidimensional in nature, that there were low to
moderate positive correlations with past behavior, and that self-efficacy was unrelated to
pre-treatment motivation but significantly positively related to pre-treatment levels of
social support. In terms of outcome, their results showed significant positive correlations
between self-efficacy and abstinence status, and negative correlations between self-efficacy
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and rate of smoking at the one-, two-, three- and six-month follow-ups, although these
results were not significant when the sample was restricted to those who had attained
abstinence by the end of treatment. They also demonstrated that self-efficacy at earlier
follow-up points was highly correlated with self-efficacy at later points. Baer et al.
concluded that self-efficacy has incremental predictive validity for smoking rate but not for
smoking status, and that a model in which both self-efficacy and smoking status made
independent contributions to subsequent smoking status was supported best by their data.
Self-Efficacy and Alcohol Treatment
Burling, Reilly, Moltzen, and Ziff (1989), citing a lack of self-efficacy research in
relation to treatment for drug- and alcohol-related problems, set out to examine a series of
questions with a group of 419 alcohol and other drug abusers in a therapeutic community
treatment setting. Using a modified version of Annis's (1986) Situational Confidence
Questionnaire (SCQ), they wanted to determine: (a) ifthere were baseline differences in
self-efficacy between alcoholics and drug users, (b) if self-efficacy increased during
treatment, (c) if those with high self-efficacy at discharge were less likely to relapse, (d) if
there were self-efficacy differences between abstinent versus relapsed groups at any of
several monthly follow-up points, and (e) if those who eventually relapsed had correctly
identified the circumstances surrounding the relapse in ratings made during treatment.
Although 419 subjects were admitted to the study, only 56 could be followed after
discharge. Results showed that: (a) there were no differences between alcohol and other
drug users at baseline, (b) there were significant increases in SCQ scores from baseline to
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discharge, (c) abstinent and relapse groups did not show differences in self-efficacy at
discharge, ( d) those who abstained did show higher follow-up self-efficacy scores than
those who had relapsed, and (e) more than half of those who relapsed had correctly
identified the circumstances surrounding their relapse. Although Burling et al. questioned
the reliability of the self-efficacy ratings given by their patients, their results do not conflict
with research in smoking cessation, and it seems equally likely that other methodological
factors -

such as the low percentage of follow-ups successfully completed over a six-

month period -

may have created problems in their study.

Solomon and Annis (1990) looked at the relationship between self-efficacy and
outcome expectancies for 100 men in residential alcoholism treatment and at a threemonth follow-up. They were particularly interested in comparing self-efficacy as measured
by the SCQ to the predictive validity of their outcome expectancy scales, which were
constructed in a way similar to the pros and cons scales of Velicer et al. (1990). These
investigators collected both types of expectancy measures at intake and again at three
months after discharge, comparing them to measures of the quantity and frequency of
alcohol consumption at follow-up. They found that SCQ scores improved from baseline to
follow-up, while the outcome expectancy measures did not. Overall, they found no
relationship between their follow-up measures and either outcome expectancy or selfefficacy, but when restricted to those who drank at follow-up, the SCQ was found to
account for 16% of the variance in quantity/frequency. Comparing three models of selfefficacy and outcome expectancy effects, they rejected a multiplicative combinatorial
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model and a model of parallel influence, concluding that their data best supported a model
in which outcome expectancies were positively correlated with self-efficacy but did not
provide incremental predictive power.
Examining the stages of change model (Prochaska & DiClemente, 1982) in relation
to attendance at Alcoholics Anonymous (AA), Snow, Prochaska, and Rossi (1994)
questioned 191 abstinent individuals who had once had drinking problems. They wanted
to assess processes of change, compare self-changers to those who attended AA, and
examine whether or not levels of AA involvement were associated with distinct patterns of
personal characteristics. In addition to other measures, participants completed a selfefficacy scale sent to them by mail. Results showed no differences in self-efficacy levels by
categories of AA attendance, nor were differences in self-efficacy found for those at
various stages of change, even when AA attendance was used as a covariate. It should be
noted, however, that this was an entirely retrospective study in which the sample was
restricted to those who had been abstinent for some time.
Finally, Di Clemente, Carbonari, Montgomery, and Hughes (I 994), in an attempt to
validate their newly-created alcohol abstinence self-efficacy scale, compared several selfefficacy factor models using the self-reports of 266 outpatient alcoholics. They found that
a four-factor solution fit their instrument best, demonstrating good reliability and
discriminant validity, although no measures of predictive validity were reported.
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Hypotheses of the Present Study
The paucity of self-efficacy applications in the area of treatment for alcohol and
drugs other than nicotine should be apparent from this brief review. This situation is
somewhat surprising given the central role this construct is thought to play in models such
as the stages of change (Prochaska & DiClemente, 1982) and relapse prevention (Annis,
1986; Marlatt, 1985) approaches. Clearly, additional work in this area is called for, and the
present study was designed in part to address this issue.
In the model proposed here, MMCD treatment is seen as an amalgam of
motivational interventions, enforced abstinence, and skills training that affects outcome
after discharge primarily by enhancing alcohol abstinence self-efficacy. Based on this view
ofMMCD treatment, it was hypothesized that to the extent that the individual participates
in the treatment process, he or she would be exposed to treatment components (e.g.,
persuasion, models, cognitive elaboration, visceral reactions, skills training) that increase
self-efficacy to abstain from alcohol/drug use. Given these two intermediate processes
(i.e., participation and self-efficacy change), it was predicted that increased abstinence
self-efficacy (confidence) would result in persistence in alternative coping behaviors and
enhancement strategies after discharge. In other words, higher abstinence self-efficacy at
discharge was expected to forestall a return to alcohol use, which would be manifested as
increased relapse latency -

i.e., longer time to first use after discharge from treatment.

CHAPTER4
METHOD
Overview of the Proposed Model
The hypothesized model includes both a measurement model and a path model.
The measurement model constitutes a set of confirmatory factor analyses for three of the
four data collection panels (i.e., baseline, process, and discharge). The path model consists
of two interlocking mediation analyses involving the following questions: (a) Does
participation in treatment increase self-efficacy at discharge, controlling for prior levels of
risk? and (b) To what extent does self-efficacy at discharge mediate the effect of
participation during treatment on outcome after discharge?
The measurement model. Based on previous research (cf, Cooper, Frone, Russell,
& Mudar, 1995; Parrella, l 996a, l 996b ), risk of use - the first data collection panel,
corresponding to baseline -

was conceptualized in this study as a second-order factor

underlying two types of positive outcome expectancies motivating alcohol use: coping
expectancies and enhancement expectancies. Coping is defined here as use of alcohol to
escape, avoid, or otherwise regulate negative emotional, interpersonal, and physical states,
while enhancement is defined as alcohol use in the service of increasing positive emotional
or social experience. Based on an assessment of the frequency of alcohol use in coping and
enhancement situations in the six months prior to treatment entry, risk was considered an

22

23
index of the degree to which positive outcome expectancies drove pre-treatment alcohol
consumption.
Since abstinence-oriented MMCD treatment programs are thought to have their
effects by engaging patients in a self-directed change process under the guidance of
counselors and peer role models, participation corresponding to treatment process -

the second data collection panel,

was conceptualized here as consisting of

involvement in the daily activities of the program, paying attention to educational materials
such as lectures and films, and contributing during effortful activities and insight-oriented
groups. Under the assumption that the active ingredients ofMMCD treatment (i.e.,
elements corresponding to Bandura's (1977) four sources of self-efficacy information) are
stochastically distributed among the various activities, materials and experiences
encountered during the treatment stay, participation served in this study as a control for
patient motivation, compliance, and within-treatment self-selectivity.
Alcohol abstinence self-efficacy, or confidence corresponding to discharge -

the third data collection panel,

was, like risk, considered to be a second-order factor

underlying abstinence self-efficacy in coping and enhancement situations. Since the
referents for these two constructs (risk and confidence) are exhaustive and mutually
exclusive behavioral alternatives (i.e., use versus abstinence), risk and confidence were
conceptualized as reciprocally related: high risk of use implies low confidence to abstain
from use, and vice versa. Just as risk -

i.e., expectancies about the value of alcohol use as

a method of coping with negative experience or enhancing positive experience -

drives
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consumption and indexes the likelihood of continued drinking, confidence (self-efficacy to
abstain from alcohol use in coping and enhancement situations) is seen as driving
abstinence, making it useful as a predictor of the likelihood of continued abstinence. Like
participation, which was used to operationalize motivation and the self-selective treatment
implementation that presumably results, confidence was used to operationalize a second
factor critical to assessment ofMMCD effects, the extent to which the "conversion"
process believed to mediate treatment outcome occurred. Since risk and confidence were
considered to be reciprocally related, these concepts were treated as negatively correlated
indices of self-efficacy to abstain from substance use. Furthermore, since the instruments
used to collect risk and confidence self-assessments were congeneric measures with
parallel scale structures, correlated errors of measurement were anticipated.
Outcome, the fourth and final data collection panel, was defined primarily as the
length of time to first use of alcohol or drugs after discharge. Research suggests that about
two-thirds of all those who return to alcohol or drug use after treatment do so within the
first six months after discharge (cf, Hunt, Barnett, & Branch, 1971 ). In this study, time to
first use (latency) was defined as the number of weeks that elapsed within the six-month
follow-up span before the use of alcohol or drugs first occurred. Since latency was
measured with a single observed indicator in this study (i.e., self-report of time to first use
at follow-up), a sensitivity analysis (cf, Marsh, 1990) was employed, rather than a
confirmatory factor analysis, for this data collection panel.
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The path model. The pair of interlocking mediational processes hypothesized to
transmit MMCD treatment effects are described below. Figure 2 depicts the fully saturated
path model on which this chain of transmission was based, with direct paths labeled for
reference in the discussion that follows. The first mediational analysis is represented by
paths A, B, and C, constituting, respectively: (a) the effect of prior risk on participation in
treatment; (b) the effect of risk on confidence, controlling for participation; and ( c) the
effect of participation in treatment on confidence at discharge, controlling for prior risk.
Path A in this model indicates the extent to which positive expectations of use affect
participation in treatment. It was hypothesized that this effect would be negative. Path B
represents the stability of self-efficacy over time. Since risk and confidence were
postulated to be reciprocally related, it was hypothesized that path B would also be
negative. Path C, representing the effect of participation in MMCD treatment on selfefficacy at discharge, was predicted to be positive. Taken together, paths A, B, and C
addressed the question "Does participation in treatment influence self-efficacy at discharge
once the effects of prior risk have been controlled?"
Paths C, D, and E constitute the second set of mediational pathways. As noted
above, path C, the direct effect of participation in treatment on self-efficacy at discharge,
was predicted to be positive. Path D assesses the degree to which abstinence self-efficacy
predicts the latency of subsequent alcohol/drug use. Since this has been demonstrated in
prior smoking cessation research, it was predicted that this path would have a positive
coefficient. Path E, representing the effect of participation on outcome not mediated by
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self-efficacy, was also hypothesized to be positive. Taken together, paths C, D, and E
addressed the question "To what extent are effects on outcome that can be attributed to
treatment participation mediated by self-efficacy?"

Figure 2
Saturated Latent Variable Path Model

Note. Circles indicate latent variables and arrows represent causal pathways. Letters A - F
refer to direct effects discussed in the text. Risk = risk of use; Participation = participation
in treatment; Confidence = abstinence self-efficacy; Latency = time to first use.

The final direct path contained in the saturated model, path F, is the residual effect
of risk on relapse latency, controlling for participation and self-efficacy. Like other paths
emanating from risk, this effect was predicted to be negative. Two total effects, not
labeled in Figure 2, were also of interest. These were: (g) the total effect of participation
on outcome (i.e., the direct effect in path E, plus the indirect effect represented by the
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product of paths C and D); and (h) the total effect of risk on outcome (i.e., the direct
effect of path F plus the indirect effects represented by A*C*D, A*E, and B*D).
Subjects
Subjects were 109 men and women who had been admitted as inpatients to a large
Midwestern substance abuse hospital for treatment of their alcohol abuse (and, in some
cases, for the abuse of other drugs as well as alcohol). Study subjects were all volunteers
who participated in a larger study of treatment process issues (see Procedures, below). All
volunteers for the larger study were included in the present sample, providing they met the
following conditions: (a) they reported use of alcohol in the month prior to treatment,
(b) there was no evidence of coexisting eating disorders, and (c) they completed all four of
the instruments used in this study (see Measures, below). The first two conditions were
employed to reduce the heterogeneity of the sample and ensure significant alcohol
involvement on the part of study participants. The third condition was required because
the main focus of the present study was an analysis of the covariation of self-efficacy,
participation in treatment, and outcome at six months after discharge.
The 109 individuals who met these conditions (71 men, 65%, and 3 8 women,
35%) ranged in age from 20 to 74 (M= 39.7, SD= 12.4); twenty-five percent (25%) were
under 30, and 27% were over 45. Most (98%) were white, 42% were married, and 25%
were living alone at the time of admission. Eighty-five percent (85%) of subjects were
high school graduates, and 60% were employed full time. This was the first treatment
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episode for 54%, and 29% reported a positive family history of alcohol and/or other drug
abuse treatment.
Procedures
All data used in the present study were obtained from an archival data set derived
from a two-year study of alcoholism treatment, the Treatment Process Study (TPS;
Parrella, Filstead & Ross, 1993), which was funded by the National Institute on Alcohol
Abuse and Alcoholism (NIAAA; Grant No. 08455). The principal investigator for the TPS
granted the present author access to selected portions of the TPS data set for the purpose
of conducting the research described here.
Overview of the TPS. The TPS was designed to operationalize the components
and processes of treatment in a standard, abstinence-oriented, inpatient treatment program
patterned after the Minnesota model (Cook, 1988a, 1988b). The overall aim of the TPS
was to construct a detailed "map" of treatment processes in terms of the activities and
services constituting treatment on a day-to-day basis. The main goals of the study were to
examine whether or not all patients got the same types and amounts of services, and to
explore perceptions, motivation, effort, and mood changes during the program. The TPS
included measures of pre-treatment expectations, differential service utilization during
treatment, perceived program difficulty, and the impact of individual service components.
These data were collected in face-to-face interviews and self-report questionnaires filled
out at baseline and discharge, and by means of a self-monitoring workbook (the Treatment
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Experience Workbook, TEW) that patients filled out each night during treatment at the
end of the day before they went to bed.
Treatment program characteristics and operation. The treatment facility at which
the TP S was conducted was a licensed, 104-bed substance abuse hospital admitting about
1800 patients a year. During the TPS, approximately forty percent (40%) of admissions
were referred out to other programs or services after a 3-5 day detoxification period.
Most of those who remained stayed from 2-4 weeks and received care in an abstinenceoriented, educational MMCD program predicated on the disease model of addiction and
the 12-step self-help philosophy of Alcoholics Anonymous. Treatment services offered at
this site included focus groups, lectures, films, medical care, psychiatric management,
medication, recreational activities, self-help literature, individual counseling, group and
family therapy, employer conferences, and self-help group meetings.
TPS procedures. Within 24 hours of admission, all new patients were solicited for
participation in the TPS. A short video was shown on the detoxification and assessment
units describing the purposes and procedures of the study. The principal investigator for
the TPS attended these sessions and answered questions raised by patients. Those who
agreed to participate were asked to read and sign a consent form and provide additional
information to enable follow-up after discharge. Then, over the course of the next two
days, study participants were interviewed and asked to complete several questionnaires in
addition to the standard battery of tests obtained for clinical use.
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During the initial testing session, study participants were given the first of a series
of workbooks (TEW) containing forms for daily self-monitoring. They were instructed in
the use of the workbook in face-to-face interviews and asked to go through a "dry run" in
which they reconstructed the previous day's activities and experiences. Subjects returned
to the research center on the second day to complete the remaining TPS instruments and
review the first day of in situ use of the workbook. Although invited to return to the
research center at any time, especially if they had questions, subjects' were scheduled to
return once each week to get a new workbook, review the one they turned in, and clarify
questions about program activities or completion of workbook sheets. Just before
discharge, they came to the research center again to turn in their final workbook and
complete retest versions of baseline instruments.
At the scheduled six-month follow-up, those who gave consent for follow-up were
called by interviewers in the attempt to locate them and conduct a telephone interview.
The study protocol called for 15 phone call attempts per subject, spread over various
times of the day and various days of the week. If phone contacts were unsuccessful, two
attempts were made to contact subjects through the mail. A span of one month after the
scheduled follow-up date was allowed for contact. If phone and mail contact attempts
failed, subjects were coded as "lost." If contacts succeeded but subjects refused
participation, they were dropped from the follow-up and coded as "refusers." If subjects
consented to be interviewed, a l 5-to-30 minute structured follow-up interview was
conducted over the phone.
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Interviews were conducted by trained interviewers using structured interview
guides. Questions were framed concerning the six-month period "since discharge."
Subjects were assured of their confidentiality, asked to confirm the collateral information
provided on the consent form signed during treatment, and permission was requested to
contact collaterals. Subjects were then guided through a self-assessment of compliance
with discharge recommendations, self-help involvement, contact with treatment agencies,
and incidents of alcohol and drug use, including multiple substances and patterns of use. If
the subject was part of the group randomly selected for an interrater reliability substudy,
he or she was also asked to consent to be re-interviewed.
Additional procedures for the present study. To obtain data for the present study
from the TPS archive, administrative records were used to determine which subjects met
the three conditions outlined above (viz., alcohol use, no concurrent eating disorders, and
presence of the instruments used in this study). In order to protect the confidentiality of
TPS participants, all information used to identify individual subjects was removed from the
portion of the TPS data base used in this project.
Measures
Demographic and clinical variables. Demographic and clinical information was
taken from the TPS administrative record and from the Alcohol and Substance Abuse
Questionnaire (ASAQ; Parrella, Filstead & Ross, 1990), a 16-section paper-and-pencil
self-report instrument. The ASAQ provides an overview of demographics, the historical
development of alcohol and substance use patterns, prior treatment history and family
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history of treatment, quantity and frequency measures for alcohol and other drugs, and
psychosocial, physiological, and behavioral measures of consequences due to alcohol and
other drug use. For this study, only the sample descriptors listed under Subjects, above,
were abstracted.
Panel 1: Risk. Utilizing Bandura's (1977, 1986) explication of self-efficacy and
Marlatt's (1985) analysis of the relapse process, Annis (1986) proposed a relapse
prevention model for treatment of alcoholics based on the idea that treatment will be
effective to the extent it increases self-efficacy to abstain from alcohol use in alcoholrelated situations in the natural environment. To provide a target for efforts directed at
improving self-efficacy, this approach begins with a highly detailed microanalysis of risk
situations. The result of this microanalysis constitutes a classic functional analysis
(Bootzin, 197 5) of drinking behavior, generating an individualized hierarchy of risk areas
for use in treatment planning and revealing the strength of alcohol outcome expectancies
on the basis of situation-specific assessments of habit strength or risk of use.
The 100-item questionnaire used to conduct this functional microanalysis, the
Inventory of Drinking Situations (IDS), was designed to assess situations in which the
client drank heavily over the past year. Annis's (1986) development of the IDS drew upon
several sources, including discussions with clinicians and alcoholics. As recommended by
Bandura (1977) and others (e.g., Ajzen & Fishbein, 1977), IDS risk assessments are made
with respect to highly specific situations. The final set of items comprises eight categories,
divided into two major classes: intrapersonal states, where drinking occurs in response to
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an event that is primarily psychological or physical in nature; and interpersonal states,
where a significant influence of another individual is involved. The five subscales classified
as intrapersonal are: negative emotional states (NES); negative physical states (NPS);
positive emotional states (PES); testing personal control (TPC); and urges/temptations
(U/T). The three interpersonal subscales are: interpersonal conflict (IPC), social pressure
to drink (SP), and positive social situations (PSS). This classification scheme was derived
largely from Marlatt' s ( 1985) content analysis of interviews with chronic male alcoholics
about the circumstances surrounding their first relapse after alcoholism treatment.
The variant of this questionnaire used in the present study, the Inventory of
Drinking and Drug Situations (IDDS), was a modification of the instrument developed by
Annis (1986), used with her permission. The IDDS content was identical to the IDS,
except that the instructions and individual items were modified to refer to situations of
heavy drinking and/or drug use. The IDDS used in this study was administered as a paperand-pencil self-report, in which the individual indicated the frequency with which he/she
drank or used drugs heavily over the past year, for each of 100 situations, using a fourpoint rating scale (I =never, 2 =rarely, 3 =often, and 4 =almost always). The eight
subscale scores corresponding to the categories listed above were obtained by adding
responses within each category. These subscales can be used in raw form, or they can be
converted to problem indices, calculated as percentages of maximum scale value. The
problem index scores, each ranging from 0 (no risk) to 100 (high risk), were used in the
present investigation, and two of the subscales, TPC and U/T, were omitted from the
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analysis, since preliminary work suggested a higher degree of factor complexity for these
scales than for the remaining six (cf Parrella, l 996a}.
Panel 2: Participation. Participation scores were derived from TEW sheets. Since
abstinence-oriented MMCD treatment involves engaging patients in a self-directed change
process under the guidance of counselors and peer role models, participation was
conceptualized as a multidimensional variable consisting of participating in the daily
activities of the treatment program, paying attention to educational materials such as
lectures and films, and contributing during insight-oriented group activities. The items
comprising the participation index are listed in Table I. Each item was answered on a sixpoint scale anchored with the labels I

=

not at all and 6 = very or very much.

Table I
Participation Items

How much effort did you put into treatment today overall?
How hard did you work today?
Were you interested and paying attention?
Were you motivated?
How much did you participate in today's treatment activities?
Did you contribute when you were in groups?

Although a participation score could, in theory, have been calculated for each day
of inpatient treatment, program activities were concentrated on weekdays, so attention
was restricted to TEW sheets completed Monday through Friday. Furthermore, since
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individual patients within this sample remained in treatment for varying lengths of time,
summary participation scores computed across the full length of stay might have unfairly
weighted the scores of some subjects over others. Thus, the approach taken here involved
computing mean participation item values for all valid non-weekend sheets completed
during the first five weekdays in active treatment (i.e., the first five non-weekend days
after the period of detoxification). Besides equating subjects in terms of the span over
which participation was calculated, this procedure was considered advantageous in that it
represents an assessment of participation early in treatment, during a critical phase of
program activities. To examine the effect of this computational procedure on study
findings, results were compared to those obtained using participation scores computed
from all non-weekend sheets across the full length of stay, and length of stay itself
(measured in days) was examined as an alternative means of operationalizing participation.
Panel 3: Confidence. Annis' s ( 1986) Situational Confidence Questionnaire (SCQ)
was developed as a companion instrument to the IDS, containing 100 parallel items used
to assess Bandura' s ( 1977) concept of self-efficacy with regard to the perceived ability to
cope with alcohol. Individuals are instructed to imagine themselves in each situation and
to rate how confident they are that they would be able to resist the urge to drink heavily in
that situation. SCQ responses are given on a six-point "percent confident" rating scale (0,
20, 40, 60 , 80, 100, where 0% and 100% are anchored with the labels 0

=

not at all

confident and 100 = very confident). SCQ scales are organized into the same eight areas
as the IDS (i.e., NES, NPS, PES, TPC, U/T, IPC, SP, and PSS), but following Bandura
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( 1977), three types of scores can be computed for each category: (a) self-efficacy level,
defined as the number of items with ratings of 60% or higher; (b) self-efficacy strength,
defined as the sum of items within the scale; and (c) self-efficacy generality, calculated as
the correlation of the strength score across categories.
The SCQ variant employed in the present study was a modification of Annis' s
(1986) instrument, used with her permission. The SCQ used here was identical to Annis' s
version in content, except that instructions and individual items were modified to refer to
situations of heavy drinking and/or drug use. In addition, because the treatment program
was abstinence-oriented, Annis' s instructions were also modified to read "resist the urge
to drink or use drugs," instead of"resist the urge to drink heavily." In this investigation,
self-efficacy strength scores were used, and these were converted to the same 0-100
problem index metric applied to the IDDS. As with the IDDS, two SCQ subscales (TPC
and U/T) were excluded from analyses, since preliminary work suggested a higher degree
of factor complexity for these scales than for the remaining six (Parrella, l 986b ).
Panel 4: Outcome. Two measures of treatment outcome were taken directly from
self-reports on the six-month follow-up interviews: relapse status and relapse latency.
Both outcome measures were used as a gauge of persistence in efforts to abstain from
alcohol and drug use. The status variable indicated whether or not the individual reported
any drinking or drug use after discharge, and was coded simply as 0 (abstinence) or 1
(substance use). Relapse latency was defined as the amount of time, in weeks, between
discharge and the first use of alcohol and/or other drugs after discharge. To control for
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minor variability in the time span over which six-month follow-up data were collected,
latency was converted to a 0-100% metric reflecting the amount of the follow-up time
span that elapsed before first use, with shorter latency values representing earlier time to
first use. All abstinent subjects were assigned a value of 100% for latency, indicating the
maximum possible time to first use (i.e., since abstinent individuals did not use alcohol or
drugs, post-discharge substance use remained entirely latent). As a check on this coding
procedure, all analyses were repeated using raw latency scores (i.e., time to first use in
weeks), yielding essentially identical results.
Supplementary measures. One other workbook variable, the mean number of topic
groups attended per day during the first week of treatment (NTOPIC), was also included
in this study for the purpose of conducting supplementary analyses. Six topic groups were
included in this count: (a) seminar, (b) bridge group, (c) compulsive behavior focus group,
(d) leisure counseling, (e) relapse focus group, and (f) spiritual growth. For each daily
workbook sheet, study participants indicated whether or not they attended each group,
and the daily topic score was a simple count of the number of groups attended that day.
The value used in this study first week of treatment -

NTOPIC, the mean number of daily topic groups in the

was considered an alternative measure of treatment exposure,

comprising that set of optional treatment-related discussion groups using more highly
personalized and individualized methods, such as role-playing, to focus on recoveryrelated issues. Like participation, the NTOPIC score was calculated as a mean of the daily
topic scores from all valid non-weekend sheets completed during the first five weekdays in
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active treatment, but this procedure yielded a single NTOPIC value, rather than a set of
six items.
Data Analyses
Preliminaries. All analyses were conducted with the SPSS implementation of
LISREL 7.2 (foreskog & Sorbom, 1989). Prior to formal analyses, all data were assessed
in terms of distributional properties, particularly deviations from normality and excessive
kurtosis, which affect the suitability of variables for inclusion in covariance structure
analysis. Maximum likelihood estimation was used to derive all factor and path models,
and a per-comparison alpha level of .05 was used within each analysis block to assess
statistical significance for likelihood ratio (LR) step tests and model chi-square values (see
below). Given the relatively small number of subjects, no alpha adjustment was applied to
correct for the number of tests performed, since power to detect small effects given the
size of the sample was low. All conclusions were also assessed at the .10 alpha level, and
differences found are noted. Although covariance matrices were used as input for all
analyses, completely standardized parameter estimates are reported here for ease of
interpretation.
Assessment criteria. The usual logic of significance testing is reversed in evaluating
the overall fit of covariance structure models. That is, a non-significant chi-square value
indicates that it is reasonable to accept the hypothesis that the constraints imposed by the
model are valid. Since the chi-square is an omnibus test of the hypothesis that the residuals
(the differences between the observed and model-implied parameters) do not differ
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significantly from zero, non-significance indicates that the proposed model represents a
plausible account of the processes that generated the observed data (Bollen, 1989).
However, this use of the chi-square statistic has disadvantages that make assessing
goodness-of-fit problematic. In particular: (a) it depends on a number of assumptions that
are unlikely to be satisfied in practice (Bollen, 1989); and (b) chi-square values increase
with increasing sample size, so a model may be rejected in large samples even if it
represents the data well, while insufficient power may lead to inflated Type II error in
small samples (Tanaka, 1993).
Several investigators have called for a deemphasis on the dichotomous decision
strategy epitomized by the classical hypothesis testing approach and a greater emphasis on
measures of comparative fit in evaluating covariance structure models (e.g., Bentler &
Bonnett, 1980; Breckler, 1990; McDonald & Marsh, 1990; Tanaka, 1993). This strategy
uses the fit of a baseline model - usually a "null" baseline in which all indicators are
assumed to be uncorrelated -

against which to compare the fit of alternative models.

That strategy was adopted in the present investigation, but even so, there appears to be no
entirely satisfactory and universally-accepted goodness-of-fit statistic (Tanaka, 1993).
Accordingly, multiple indices were used in the present investigation as guidelines to
evaluate the goodness-of-fit of the models examined. In addition to the chi-square value,
degrees of freedom, chi-square goodness-of-fit (GFI) statistic, and root mean square
residual (RMR) produced by LISREL, the following additional indices are reported:
(a) the ratio of the chi-square value divided by its degrees of freedom, (b) the nonnormed
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fit index (NNFI; Tucker & Lewis, 1973; Bentler & Bonnett, 1980), (c) the normed fit
index (NFI; Bentler & Bonnett, 1980), ( d) the incremental fit index (IFI; Bollen, 1989),
and (e) the comparative fit index (CFI; Bentler, 1990).
A cursory overview of fit statistics presented in recent published reports of
covariance structure models shows wide variation and no consistent pattern, although
Tanaka (1993) provides an interesting approach to their classification. A complete account
of comparative fit indices is beyond the scope of this paper, but a brief overview of those
used here follows.
1. Since the expected value of a chi-square variate is its degrees of freedom, the
chi-square/df ratio evaluates how many times larger the chi-square estimate is than its
expected value. There is no consensus on what represents "good" fit using this index,
however, and proposed values range from 5 on down.
2. The NNFI takes into account sample size effects and it shows good
performance as values approach one, but it can be anomalously small, especially in large
samples. Furthermore, its sampling variability is substantially larger than some of the other
indices, and since it is not normed, it can fall outside the O-to-1 range, making
interpretation difficult.
3. The NFI represents the incremental improvement in fit of the alternative model
relative to the baseline in a standard metric ranging from 0 to 1. The NFI does not control
for degrees of freedom, however, so apparent improvements in fit can be obtained merely
by adding parameters or "overfitting" the data. Also, the mean of the sampling distribution

41
of the NFI is larger for big than for small samples, so larger samples may give the
impression of better fit even if the identical model holds. In addition, the NFI may not
reach one even if a model is correct, especially in small samples.
4. The IFI takes degrees of freedom into account and lessens the dependence on
sample size, but it is not normed to the O-to-1 range, and sample size does influence its
calculation, such that the IFI is larger for small sample sizes than for big ones.
5. The CFI is normed and has small sampling variability, but it appears to have a
small downward bias. For more complete accounts of these benefits and drawbacks, the
interested reader is referred to Bentler and Bonnett (1980), Bollen (1989), Breckler
(1990), McDonald and Marsh (1990), and Tanaka (1993).
Stepped tests of nested models. Another strategy is applicable for testing nested
models. A more restrictive model is nested within a less restrictive model if the two
models are identical except for constraints in the more restrictive model setting some of its
parameters to a constant or to some function of its free parameters (Bollen, 1989). For
example, any version of the saturated path model described above in which a single path
or set of paths has been constrained to zero is nested within the fully saturated path model,
because such models are identical except for the constraints in the more restricted model
setting paths to zero. When models are nested, the likelihood ratio (LR), or chi-square
difference test, provides a test of significance of the added constraints. If the LR statistic is
significant, this indicates that freeing the constraints that distinguish the more from the less
restrictive model produces an improvement in fit, making it unlikely that the more
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restrictive model is correct. Thus, in addition to the adjunctive goodness-of-fit indices
listed above, the LR statistic was also employed in this study to compare nested models.
Analysis block 1: Confirmatory factor analysis for data collection panels. In a
previous investigation (Parrella, l 996a), the first of two studies showed that a correlated
Coping and Enhancement factor solution with correlated measurement errors (labeled M4
in that study) provided excellent fit for the six IDDS scales from a group of 453 inpatient
alcohol and drug abusers tested at admission to treatment, whereas both a single-factor
solution (labeled Ml) and a two-uncorrelated factors solution (labeled M2) did not.
Although a correlated two-factor solution (M3) provided good fit, the M4 solution which included correlated errors designed to model potential method effects -

produced

a statistically significant increment in fit, and was judged to be supported best by the data.
In the second study of that investigation, cross-validation of the M4 solution in an
independent sample demonstrated invariance of form and factor loadings, but the
hypothesis of invariance was rejected for latent variable covariances and observed variable
measurement errors. In a related investigation (Parrella, l 996b), invariance of the M4
solution as applied to IDDS data was confirmed in a third sample, and the M4 solution
was extended to the SCQ. The IDDS and SCQ factor solutions were then merged in a
path analysis, demonstrating a high degree of fit, which improved significantly with the
addition of correlated longitudinal errors between parallel IDDS and SCQ scales.
Given the level of fit and stability across independent samples demonstrated for the
M4 solution in previous investigations, the first analysis block in the present study applied
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the M4 solution directly to the IDDS and SCQ data from subjects in this sample to test
measurement hypotheses for these instruments. Goodness-of-fit for the M4 solution was
assessed individually for the IDDS and SCQ by comparing each model to its respective
null baseline, using the chi-square value and adjunctive fit indices described above. It was
predicted that these two confirmatory factor analyses would show excellent fit for the M4
factor solution as applied to IDDS and SCQ data from the present sample.
A similar procedure was applied to the participation items. First, corresponding
pairs of items were combined, yielding three indicators representing effort ("How much
effort did you put into treatment today overall?" plus "How hard did you work today?"),
motivation ("Were you interested and paying attention?" plus "Were you motivated?"),
and participation ("How much did you participate in today's treatment activities?" plus
"Did you contribute when you were in groups?"). Then a null baseline model was
specified containing the three independent indicators and no common factors, against
which the goodness-of-fit of the final Participation model was tested. Last, the
Participation factor was specified as a single common factor on which all three indicators
loaded. In order to provide a measurement scale for the latent variable, the loading of the
indicator named participation was constrained to equal one (cf, Bollen, 1989). Since a
three-indicator model with two free loadings is just identified, fitting the data perfectly and
yielding a chi-square value of zero with no degrees of freedom, in order to conduct
goodness-of-fit tests, this model was modified by constraining the effort indicator to equal
one, as well (cf., Hayduk, 1987). Goodness-of-fit for this factor solution was assessed in
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comparison to the null baseline, using the chi-square value and adjunctive fit indices. It
was predicted that the Participation factor derived in this way would fit the data well.
Analysis block 2: Testing paths in the saturated model. In order to assess the
significance of the individual paths in the saturated model, the complete path model was
examined in this set of analyses. Since the number of subjects in this study was small
relative to the number of free parameters estimated in a path model using all variables, the
Coping and Enhancement factors of the IDDS and SCQ were considered separately. Thus,
two risk-participation-confidence-outcome (RPCO) path models were examined, each of
which included three of the indicators from both the IDDS and SCQ: a RPCO model for
Coping (using the NES, NPS, and IPC scales) and a RPCO model for Enhancement (using
the PES, PSS, and SP scales). Parallel procedures were used to examine both models.
First, a null baseline was specified for each RPCO model in which the 10 indicators
(i.e., three IDDS scales, three Participation indicators, three SCQ scales, and the outcome
indicator) were constrained to be uncorrelated. Then a fully constrained path model was
specified in which factor models derived from the previous analysis block were applied to
the data and all six of the predictive paths (i.e., paths A through F, as described above)
were constrained to zero. Finally, six additional models were composed, each of which
was generated by freeing one of the six paths individually while the remaining five paths
were constrained to zero. To assess statistical significance, each of these six step models
was compared to the nested fully constrained path model using the LR statistic. Once the
path model had been "stepped" in this fashion, a final RPCO model was generated in
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which only significant paths were retained. This final trimmed RPCO model was then
compared to the null baseline model to assess goodness-of-fit, using both the chi-square
statistic and the adjunctive goodness-of-fit indices. To repeat, this sequence was
conducted separately for the Coping RPCO and the Enhancement RPCO, and these
procedures were conducted twice, once using relapse status as the outcome measure and
once using relapse latency as the outcome measure. The Appendix lists covariance
matrices for RPCO models involving latency, along with the LISREL commands used to
generate the baseline, unconstrained, and trimmed models for Coping and Enhancement.
Analysis block 3: Power and sensitivity. Since the number of subjects in this study
was relatively small, analyses were conducted to examine the power of statistical tests to
detect predicted effects. In covariance structure models, power can be assessed for
individual parameters (such as specific factor loadings, or the predictive paths described
above), for groups of parameters, or for the model as a whole. Satorra and Saris (1985),
JOreskog and Sorbom (1989), and Bollen (1989) describe and illustrate procedures
traditionally used to estimate power in covariance structure analyses. Since power can
only be computed in relation to a specific alternative, these procedures involve specifying
parameter values for an alternative model, generating the covariance matrix for this model,
analyzing the resulting covariance matrix under the original model, and using the resulting
chi-square value to approximate the chi-square noncentrality parameter. This noncentrality
parameter is then used in conjunction with tabled values of the noncentral chi-square
distribution to estimate the power of a significance test at a given alpha level.
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Power assessment using these traditional procedures is highly sensitive to each of
the specific parameter values chosen for the alternative model, so testing power for even
moderately complex models may involve assessing a large number of combinations of
alternative parameter values. Furthermore, these techniques all evaluate the power for a
test of exact fit for a specific model, even though a model that provides a close (rather
than exact) approximation to real-world relationships is the best that can be realistically
expected (cf, Browne & Cudek, 1993). MacCallum, Browne and Sugawara (1996)
describe another method of testing power based on the root-mean-square error of
approximation (RMSEA), an index that indicates the discrepancy of model fit per degree
of freedom. Based on their own work and that of other investigators, these authors
provide a set of guidelines for interpreting RMSEA, suggesting that values less than 0.05
represent close fit, values from 0.05 to 0.08 represent fair fit, and values above 0.08
indicate mediocre or poor fit. Using the RMSEA index and these cutoff ranges,
MacCallum et al. provide procedures for computing power and determining the minimum
number of subjects required to achieve a specified level of power.
Both types of power analyses were conducted in the present investigation. For
each of the predictive paths in the two final RPCO models involving latency, power to
reject the null hypothesis that the path equaled zero given the alternative value dictated by
the size of the parameter in the freely estimated solution was computed using traditional
procedures. Since power depends in part on alpha, power was computed using a range of
alpha levels to determine whether or not the resulting increase in power that would be
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obtained using an alpha larger than .05 would affect study conclusions. For the model as a
whole, the RMSEA-based procedure was then applied to assess power under null
hypotheses of exact, close, and fair fit.
Outcome indicators in this study were inferred on the basis of responses to a single
self-report item, time to first use. In order to examine the effects of varying the level of
reliability for this indicator, a sensitivity analysis was conducted for relapse latency. In this
analysis, the reliability of the latency indicator was fixed at each of several values (viz.,
I. 0, .9, .8, .7, .6, and . 5) and the two final RPCO models were re-estimated. Foil owing
procedures illustrated by Bollen (I 989), Hayduk (1987), and Marsh (I 990), this was
accomplished by fixing the latency error term to x times the variance of the observed
latency indicator, where x was equal to one minus the reliability of the indicator.
Analysis block 4: Supplementary analyses. A number of other analyses were
conducted to examine the RPCO models. First, models were examined which included
participation items computed across the entire length of stay in place of those computed
based only on the first week of treatment. Second, length of stay itself (measured in days)
was substituted for the Participation factor and the two final RPCO models were reestimated. Third, the mean number of topic groups attended per day during the first week
of treatment (NTOPIC; see Measures, above) was included along with the Participation
factor and the final resulting models were re-estimated. These model variants were
evaluated in the same fashion described above for analysis blocks I and 2.

CHAPTERS
RESULTS
Descriptive Statistics
Table 2 lists means, standard deviations, and Cronbach's (1951) alpha for the
IDDS and SCQ scales for study subjects. IDDS and SCQ scales ranged from 0 to 100,
whereas the scale for participation items ranged from 1 to 6. For the six participation
items computed over the first week of treatment, alpha was .92 (M= 4.5, SD= 0.72).
When computed across length of stay, alpha for participation was .94 (M = 4. 5,

SD= 0.66). Subjects in this sample received, on average, 22.0 days of treatment (SD=
7. 7), which includes a mean of 2.3 days of detoxification (SD= 3.0).

Table 2
Means, Standard Deviations and Alphas for IDDS and SCQ Scales
SCQ

IDDS

SD Alpha

M

SD Alpha

Items

M

Negative emotional states (NES)

20

50.9

27.8

.97

77.8

19.0

.97

Negative physical states (NPS)

IO

36.5

25.9

.90

83.6

18.4

.92

Positive emotional states (PES)

10

49.6

27.8

.93

84.6

19.0

.94

Interpersonal conflict (IPC)

20

39.7

27.2

.97

81.5

18.3

.97

Social pressure (SP)

IO

50.1

30.5

.93

79.2

22.7

.95

Positive social situations (PSS)

10

51.3

30.6

.95

82.7

19.2

.94

Scale
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For the outcome measures, subjects had been out of treatment for a span of 205.3
days on average at the time of the six-month follow-up contact (SD= 31.4), this mean
being slightly longer than the expected six months. Sixty-nine (69) of those contacted
reported no use of alcohol or drugs (63.3%), while 40 (36.7%) reported that some use
had occurred since discharge. In absolute terms, those who reported use said that their
first use episode occurred an average of 11.3 weeks after discharge (SD= 10. 7), with a
minimum of 0 weeks (used immediately after discharge) and a maximum of 3 5 weeks.
When converted to percentage values, and including those who remained abstinent and
were assigned a value of 100 percent latency, subjects in this sample reported an average
latency of 77.0 percent of the available follow-up span (SD= 36.4). This value is, of
course, heavily weighted by those who remained abstinent. The average latency for those
who had used was 35.7 percent of the follow-up span (SD= 32.3), with a median value of
22.3 percent and a mode of zero. More than half of those who drank or used drugs did so
within the first two months after discharge. Table 3 lists means, standard deviations, and
zero-order correlations for the sixteen observed indicators used in this study.
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Table 3
Means, Standard Deviations and Zero-Order Correlations for Indicators (N = I 09)
Indicator

1.

1. rNES

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

.000 .000 .000 .000 .000 .893 .161 .835 .105 .582 .642 .133 .193 .334 .361

2. rNPS

.796

3. rPES

.516 .452

4.rIPC

.895 .753 .557

.000 .000 .000 .000 .846 .356 .697 .046 .014 .307 .021 .030 .143 .952
-

.000 .000 .000 .253 .024 .206 .459 .898 .152 .263 .098 .070 .452
-

.000 .000 .983 .125 .657 .121 .526 .356 .060 .184 .268 .773

5. rSP

.525 .414 .695 .597

6. rPSS

.583 .436 .735 .631 .916

7.EFF

.013 .019 -.111 -.002 .117 .107

-

.000 .226 .649 .369 .553 .969 .412 .232 .005 .073 .380
-

.269 .811 .517 .539 .931 .362 .174 .025 .064 .549
-

.000 .000 .585 .573 .072 .728 .856 .460 .369

8. MOT

-.135 -.089 -.216 -.148 -.044 -.023 .731

9. PAR

-.020 .038 -.122 -.043 .087 .063 .778 .715

.000 .877 .891 .330 .945 .612 .333 .235
-

.608 .776 .045 .685 .318 .275 .359

10. cNES

-.156 -.192 -.072 -.150 -.058 -.060 .053 .015 .050

11. cNPS

-.053 -.235 -.013 -.061 .004 .008 .055 -.013 .028 .824

12. cPES

-.045 -.099 -.138 -.089 -.079 -.088 .173 .094 .193 .742 .761

13.cIPC

-.145-.221-.108-.181-.115-.131 .034 .007 .039 .911 .857 .770

14. cSP

-.126 -.208 -.160 -.128 -.270 -.215 .018 .049 .097 .736 .688 .709 .727

15. cPSS

-.093 -.141 -.174 -.107 -.172 -.178 .072 .094 .106 .805 .777 .860 .821 .836

16. TTFU

-.088 -.006 -.073 -.028 -.085 -.058 .087 .115 .089 .164 .176 .170 .199 .141 .230

.000 .000 .000 .000 .000 .088
-

.000 .000 .000 .000 .068
.000 .000 .000 .077
.000 .000 .038
-

.000 .143
-

.016

M

50.9 36.5 49.6 39.7 50.1 51.3

4.5

4.6

4.5 77.8 83.6 84.6 81.5 79.2 82.7 77.0

SD

27.8 25.9 27.8 27.2 30.5 30.6

.8

.8

.8 19.0 18.4 19.0 18.3 22.7 19.2 36.4

Note. A dash ("-") indicates the diagonal; means, standard deviations, and correlations
are below the diagonal; p values for two-tailed tests of significance of correlations are
above the diagonal; small "r" prefix indicates IDDS scales, small "c" prefix indicates SCQ
scales. NES =Negative Emotional States; NPS =Negative Physical States; PES =
Positive Emotional States; IPC =Interpersonal Conflict; SP= Social Pressure; PSS=
Positive Social Situations; EFF = Effort indicator; MOT = Motivation indicator; PAR =
Participation indicator; TTFU =Time to First Use as percentage of follow-up span
(Latency).

IDDS Factors
Goodness-of-fit indices for IDDS factor models are presented in Table 4. As
expected, uncorrelated baseline models fit poorly, as demonstrated by the large and highly
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significant chi-square values. Statistics for the M4 solution containing correlated Coping
and Enhancement factors and correlated method errors, on the other hand, provided
excellent fit, as did the single-factor solutions for Coping and Enhancement considered
separately. Figure 3 presents parameter estimates for the IDDS M4 solution.

Table 4
Goodness of Fit Summary for IDDS Factor Factor Models
x2

Factor Model

d[_

2

/!_

GFI RMR X ldf NNFI NFI

IFI

CFI

Both Coping and Enhancement (all six IDDS indicators)
Uncorrelated baseline
M4, 2 correlated factors

631.4 15 .000 .320 445.4 42.1
12.6 6 .050 .962 29.2 2.1

.98

.95

.99

.98

25.4 2.0 .99

.98

1.0

.99

.99

1.0

.99

Coping Only (NES, NPS, IPC)
Uncorrelated baseline
One Coping factor

285.4
2.0

3 .000 .428 421.9 95.1
1 .161 .988

Enhancement Only (PES, PSS, SP)
Uncorrelated baseline
281.5 3 .000 .446 494.6 93.8
.307 .994 19.9 1.1
One Enhancement factor
1.1

1.0

Note. A dash("-") indicates not applicable; GFI = LISREL goodness of fit index;
RMR = root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and
CFI based on comparison to respective uncorrelated baseline.

The total coefficient of determination for observed indicators in the IDDS M4
solution was .998, with squared multiple correlations ranging from .57 to .96. This
suggests that the six observed indicators were good measures of the latent Coping and
Enhancement variables.
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Figure 3
Parameter Estimates for the IDDS M4 Solution
.058
.082

.338

.124

-.008
.427

.037

.131

$$$$$$
.958 .813 .936

.757 .981

.932

.636

Note. Circles indicate latent variables and boxes represent observed indicators. Anchored
singled-headed arrows represent factor loadings, double-headed arrows represent
association with no causal direction assumed, and unanchored arrows represent error
variance. NES =Negative Emotional States; NPS =Negative Physical States; IPC =
Interpersonal Conflict; PES =Positive Emotional States; PSS =Positive Social Situations;
SP = Social Pressure. All parameters are completely standardized estimates.

Participation Factors
Goodness-of-fit indices for Participation factor models are presented in Table 5.
Again, as expected, the uncorrelated baseline models provided poor fit, whereas the
single-factor solutions were well-supported. Figure 4 presents parameter estimates for the
Participation solution using indicators from the first week of treatment. Results suggest
that the three indicators were excellent indicators of the underlying Participation factor.
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Table 5
Goodness of Fit Summary for Participation Factor Models
x2

Factor Model

d[_ !!.

2

GFI RMR X ldf NNFI NFI

IFI

CFI

Participation in the first week
Uncorrelated baseline
One factor

196.3
.7

3 .000 .476
1 .390 .995

.327 65.4
.019 .7

1.0

.99

1.0

.99

3 .000 .421
.795 .998

.290 96.1
.004 .1

1.0

1.0

1.0

1.0

Participation across length of stay
Uncorrelated baseline
One factor

288.4
.1

Note. A dash("-") indicates not applicable; GFI = LISREL goodness of fit index;
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and
CFI based on comparison to respective uncorrelated baseline.

Figure 4
Parameter Estimates for the Week One Participation Solution
.179

.331

.272

$$$
.906 .818 .853

Note. Circles indicate latent variables and boxes represent observed indicators. Anchored
singled-headed arrows represent factor loadings and unanchored arrows represent error
variance. EFF = Effort indicator; MOT = Motivation indicator; PAR = Participation
indicator. All parameters are completely standardized estimates.
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SCO Factors
Goodness-of-fit measures for the SCQ models are displayed in Table 6. As with
the IDDS models, the uncorrelated baselines fit poorly while the hypothesized factor
structures fit well. Note, however, that in the original Enhancement-only solution, the
error variance for the PSS indicator was slightly negative, a condition known as a
Heywood case. Bollen ( 1989) suggests a number of possible causes and solutions for such
problems, one of which is to consider small negative values as essentially equal to zero.
Some covariance structure analysis programs, such as EQS (Bentler, 1989), perform this
adjustment automatically, preventing Heywood cases by holding ill-behaved parameters at
the permissible boundary (e.g., fixing the value at zero). Since LISREL does not perform
this correction automatically, the Enhancement only solution was respecified with the
error term for PSS fixed at zero. This provided a good fit to the data in this case, although
fixing a parameter in this way also yielded an extra degree of freedom for this model.
While other solutions are available and should be considered offending indicator -

such as dropping the

the size of the error term and the degree of fit for both the M4

solution and the corrected Enhancement-only solution suggested that fixing the PSS error
term at zero was the best approach in this case.
As with the IDDS M4 solution, the total coefficient of determination for observed
indicators in the SCQ M4 solution was very high (. 996). Squared multiple correlations
ranged from .70 to .97, suggesting that the six observed indicators were very good
measures of the latent Coping and Enhancement variables.
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Table 6
Goodness of Fit Summary for SCQ Factor Models

d[ p

Factor Model

GFI RMR

2

X ldf

NNFI NFI

IFI

CFI

Both Coping and Enhancement (all six SCQ indicators)
Uncorrelated baseline

760.8

M4, 2 correlated factors

2.9

15 .000 .242 251.1 50.7
6 .823 .991

3.0

.5

1.0

.99

1.0

1.0

1.0

1.0

1.0

1.0

. 1 1. 0

1.0

1.0

1.0

Coping Only (NES, NPS, IPC)
Uncorrelated baseline

339.2

One Coping factor

.1

3 .000 .401 210.9 113
1 .947 1.0

.6

.1

Enhancement Only (PES, PSS, SP)
Uncorrelated baseline
274.6 3 .000 .436 232.4 91.5
One Enhancement factor

.2

2 .91 7 .999

6. 1

Note. A dash ("-") indicates not applicable; GFI = LISREL goodness of fit index;
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and
CFI based on comparison to respective uncorrelated baseline.

Figure 5 presents parameter estimates for the SCQ M4 solution. Note that the
correlation between Coping and Enhancement factors was higher for the SCQ M4 solution
than for that derived from the IDDS. This indicates that Coping and Enhancement
abstinence self-efficacy categories may be less distinct (or, alternatively, more coherent)
than the same categories applied to risk of use, replicating the results of previous research
(Parrella, l 996b ). Overall, then, the confirmatory factor analyses conducted for the first
three data collection panels provided strong support for the measurement hypotheses of
this study, yielding a good foundation for considering the structural hypotheses
represented by the path analyses.
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Figure 5
Parameter Estimates for the SCQ M4 Solution
.043
.114

.216

.067

-.065
.202

.074

.248

$$$$$$
.941

.886 .966

.893 .962 .867

.889

Note. Circles indicate latent variables and boxes represent observed indicators. Anchored
singled-headed arrows represent factor loadings, double-headed arrows represent
association with no causal direction assumed, and unanchored arrows represent error
variance. NES =Negative Emotional States; NPS = Negative Physical States; IPC =
Interpersonal Conflict; PES =Positive Emotional States; PSS = Positive Social Situations;
SP = Social Pressure. All parameters are completely standardized estimates.

Path Tests and Final Models for Coping
Goodness-of-fit indices for the Coping RPCO models using relapse status as the
outcome measure are presented in Table 7, and comparisons among nested models
comprising the six step tests for individual paths are presented in Table 8. As predicted,
the uncorrelated baseline model provided poor fit, whereas the RPCO model fit the data
well. Contrary to predictions, however, the null hypothesis could not be rejected for any of
the six paths, as indicated by non-significant LR statistics for each of the stepped paths in
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Table 8. Thus, in this case, the final trimmed Coping RPCO using relapse status as the
outcome indicator was the same as the fully constrained path model.

Table 7
Goodness of Fit for Coping RPCO Models Using Relapse Status
x2

Path Model

d[

/!_

GFI RMR

2

X ldf

NNFI NFI

IFI

CFI

Uncorrelated baseline

874.5 45 .000 .442 159.3 19.4
RPCO, all paths constrained 28.9 33 .672 .952 30.1
.9 .97

.96

1.0

.97

RPCO, trimmed

.96

1.0

.97

28.9 33 .672 .952

30.1

.9 .97

Note. A dash("-") indicates not applicable; GFI = LISREL goodness of fit index;
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and
CFI based on comparison to uncorrelated baseline.

Table 8
Path Steps for Coping RPCO Model Using Relapse Status

d[

Model Com,earison

LR

Constrained vs. free A

0.15

Constrained vs. free B

2.44

1

.118

Constrained vs. free C

1
1

.699

Constrained vs. free D

0.15
2.32

.128

Constrained vs. free E

1.73

1

.188

Constrained vs. free F

0.46

1

.498

Note. LR = likelihood ratio test statistic

/!_

.699
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Goodness-of-fit measures for the Coping RPCO models using latency as the
outcome measure are presented in Table 9, and comparisons among nested models for the
six step tests are presented in Table 10. As for relapse status, the uncorrelated baseline
model using latency provided poor fit, whereas the RPCO models fit the data well.
Contrary to predictions, the null hypothesis could not be rejected for five of the six paths,
as indicated by non-significant LR statistics. Freeing path D did provide an improvement
in fit using .05 as a cutoff for the LR statistic. Thus, the final trimmed model for the
Coping RPCO path analysis using latency as the outcome measure contained only one
freely estimated path, path D, predicting relapse latency from confidence at discharge.

Table 9
Goodness of Fit for Coping RPCO Models Using Latency
Path Model

x2

dl

2

l!.

GFI RMR X ldf NNFI NFI

875.6 45 .000 .441 162.3 19.5
.9 .97
RPCO, all paths constrained 30.0 33 .619 .951 43.3
.8 .97
25.6 32 .779 .956 32.8
RPCO, trimmed

IFI

CFI

1.0

.97

1.0

.97

Uncorrelated baseline

.95
.96

Note. A dash ("-") indicates not applicable; GFI = LISREL goodness of fit index;
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and
CFI based on comparison to uncorrelated baseline.
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Table 10
Path Steps for Coping RPCO Model Using Latency
Model Com2arison

LR

d[_

l!..

Constrained vs. free A

0.15

1

.699

Constrained vs. free B
Constrained vs. free C

2.44
0.14

1

.118
.708

Constrained vs. free D
Constrained vs. free E

4.33
1.15

1

.037
.284

Constrained vs. free F

0.54

1

.462

1
1

Note. LR = likelihood ratio test statistic

Path Tests and Final Models for Enhancement
Goodness-of-fit indices for the Enhancement RPCO models using relapse status as
the outcome measure are presented in Table 11, and comparisons among nested models
comprising the six step tests for individual paths are presented in Table 12. As with
Coping, the uncorrelated baseline model for Enhancement provided poor fit, whereas the
RPCO model fit the data much better. Contrary to predictions, the null hypothesis could
not be rejected for five of the six individual paths. The significant path in this case was
path B, the stability coefficient predicting confidence at discharge from risk at baseline.
The final trimmed Enhancement RPCO model using relapse status as the outcome
indicator included only path B, yielding a non-significant chi-square value for the trimmed
path model.
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Table 11
Goodness of Fit for Enhancement RPCO Models Using Relapse Status

x2

Path Model

d[_ !!.

2

GFI RMR X ldf NNFI NFI

IFI

CFI

.98
.98

.94
.95

Uncorrelated baseline

812.4 45 .000 .453 185.8 18.1
RPCO, all paths constrained 47.9 33 .045 .918 40.4 1.5 .94
RPCO, trimmed
43.9 32 .078 .924 12.2 1.4 .95

.92
.92

Note. A dash ("-") indicates not applicable; GFI = LISREL goodness of fit index;
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and
CFI based on comparison to uncorrelated baseline.

Table 12
Path Steps for Enhancement RPCO Model Using Relapse Status
Model Com2arison

LR

df_

l!.

Constrained vs. free A
Constrained vs. free B

0.50
3.97

1
1

.480
.046

Constrained vs. free C

0.98

1

.322

Constrained vs. free D

2.03

Constrained vs. free E

1.73
0.02

1

.154
.188

1

.888

Constrained vs. free F

Note. LR= likelihood ratio test statistic

Goodness-of-fit for the Enhancement RPCO models using latency as the outcome
measure are presented in Table 13, and comparisons among nested models for the six step
tests are presented in Table 14. As in previous models, the uncorrelated baseline provided
poor fit, whereas the RPCO models fit the data much better. Only two of the six paths
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provided an improvement in fit, as indicated by significant LR statistics, when compared
to the Enhancement RPCO model in which all paths were constrained to zero. Freeing
path B and path D provided significant improvements in model fit. Thus, the final trimmed
model for the Enhancement RPCO path analysis using latency as the outcome measure
contained two freely estimated paths, path B (predicting confidence from prior risk) and
path D (predicting latency from confidence).

Table 13
Goodness of Fit for Enhancement RPCO Models Using Latency
Path Model
Uncorrelated baseline

x2

d[_

2

[!_

GFI RMR X ldf NNFI NFI

IFI

CFI

815.0 45 .000 .451 189.3 18.1

RPCO, all paths constrained 50.5 33 .027 .914

54.2

1.5

.94

.92

.98

.94

RPCO, trimmed

16.3

1.3

.95

.93

.99

.95

40.8 31 .112 .930

Note. A dash ("-") indicates not applicable; GFI = LISREL goodness of fit index;
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and
CFI based on comparison to uncorrelated baseline.
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Table 14
Path Steps for Enhancement RPCO Model Using Latency
Com~arison

LR

df

l!.

Constrained vs. free A

0.49

1

.484

Constrained vs. free B

3.96

1

.047

Constrained vs. free C

0.97

1

.325

Constrained vs. free D

5.77

1

.016

Constrained vs. free E
Constrained vs. free F

1.15
0.42

1
1

.284

Model

.517

Note. LR= likelihood ratio test statistic

Power
Table 15 displays the results of calculating power using traditional procedures for
different alpha levels. The level indicated by the tabled value represents the power of the
step tests to reject the null hypothesis that the specified path was equal to zero, given the
size of the parameter in the freely estimated solution and the specified alpha level. These
values correspond directly to the step comparisons reported above in Tables 10 and 14. As
can be seen from an examination of Table 15, power for tests of paths retained in the two
final trimmed RPCO models was acceptable, being above an admittedly somewhat
arbitrary cutoff level of 0.40. While raising alpha as high as .25 would bring power to
acceptable levels for four additional tests, this alpha level would affect the significance of
only one path (the B path predicting confidence from risk in the Coping solution).
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Table 15
Power to Reject Null Hypothesis for RPCO Models Using Latency
Al~ha

Path

.05

.10

.15

.20

.25

Coping RPCO model
A
-.041
0.07
B
-.153
0.34
.033
0.06
c

0.13
0.46

0.18
0.55

0.23
0.61

0.29
0.66

0.12

0.17

0.22

0.27

0.63
0.27

0.71
0.34

0.13

0.18

0.76
0.40
0.24

0.80
0.46
0.29

D

E
F

Beta

.192
.099
-.039

0.51
0.17
0.07

Enhancement RPCO model
A

.073

0.11

0.19

0.25

0.31

0.37

B

-.200

0.55

0.67

0.74

0.79

0.83

c

.114

0.21

0.51

.212

0.60

0.39
0.78

0.45

D

0.31
0.71

0.82

0.86

E

.089

0.30
0.17

0.42

-.028

0.23
0.11

0.37

F

0.15
0.06

0.22

0.27

Note. Beta = size of completely standardized path coefficient;
Tabled values represent power to reject the null hypothesis that
the specified path equals zero at the specified alpha level.

Table 16 displays power levels for the overall chi-square test ofRPCO models that
included latency, calculated using the RMSEA procedure and cutoff values specified by
MacCallum et al. (1996). Since power varies depending on degrees of freedom as well as
alpha level, power is displayed for RPCO models in which all paths were freely estimated

(df= 27) as well as for the trimmed models (df = 32 for Coping and 31 for Enhancement,
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but 32 was used in the power calculations for trimmed models). Using Maccallum et al. 's
cutoff values, exact fit was defined here as the power of the chi-square test to detect the
alternate hypothesis that RMSEA ~ 0.05 using a null hypothesis that fit was exact (i.e.,
RMSEA = 0). Similarly, close fit was defined as power to detect an alternate hypothesis
that RMSEA ~ 0.08 under a null hypothesis that fit was close (RMSEA::;; 0.05). Fair fit
was defined as power to detect the alternate hypothesis that RMSEA

~

0.08 when the null

hypothesis was fair fit (RMSEA < 0.08).

Table 16
Power at Specified Fit Levels for RPCO Models Using Latency
AlQha
Level of fit

.05

.10

.15

.20

.25

RPCO models with paths freely estimated
Exact fit

0.27

0.39

0.48

0.56

0.62

Close fit
Fair fit

0.35

0.48

0.58

0.71

0.73

0.82

0.88

0.65
0.91

0.93

RPCO models with non-significant paths trimmed
Exact fit

0.24

0.36

0.45

0.53

0.59

Close fit
Fair fit

0.31

0.44
0.78

0.54
0.84

0.61
0.88

0.67
0.90

0.67

Note. Exact fit= power to detect Ha: RMSEA ~ 0.05 when
H 0 :RMSEA = O; Close fit = power to detect Ha: RMSEA ~
0.08 when H 0 :RMSEA::;; 0.05; Fair fit= power to detect Ha:
RMSEA ~ 0.08 when H 0 :RMSEA < 0.08; Ho= null
hypothesis; Ha= alternate hypothesis; RMSEA =root-meansquare error of approximation.
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As noted previously, the hypothesis of exact fit is probably quite unrealistic for
most real-world applications. Overall, power levels for tests ofRPCO model fit were
considered acceptable. Based on tables presented by Maccallum et al., the minimum
number of subjects required to obtain a power of 0.80 under null hypotheses of either
close or exact fit would have been approximately 3 50, or three times the number of
subjects actually obtained in the present study.
Sensitivity
Results of the sensitivity analyses for the Coping and Enhancement RPCO models
using latency as the outcome measure are presented in Table 17. As expected, none of the
paths that did not directly impinge on latency (i.e., paths A, B, and C) were affected by
these analyses. Paths D, E, and F -

which comprise all the direct effects involving latency

varied in a systematic and logical fashion as the reliability of the latency indicator was

modified. Since covariance structure analysis corrects effects for unreliability in the
indicators, the result of decreasing levels of reliability was an increase in the size of the
standardized path coefficient estimates, as expected. None of the significance levels for
these parameters were affected by reliability manipulations, however.
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Table 17
Sensitivity of RPCO Path Coefficients to Varying Latency Reliability
Path
Latency Reliability

A

B

c

D

E

F

Coping RPCO with freely-estimated paths
1. 0 (original model)
.9

-.153
-.153

.033
.033

.192
.203

.099
.105

.8

-.041
-.041
-.041

-.153

.033

.215

.111

-.039
-.042
-.044

.7

-.041

-.153

.033

.230

.119

-.047

.6
.5

-.041

-.153
-.153

.033

.248
.272

.128
.141

-.051

.212

.089

-.028

.224

.094

-.029

-.041

.033

Enhancement RPCO with freely-estimated paths
1. 0 (original model) .073
-.200
.114
.073
.9
-.200
.114

-.056

.8

.073

-.200

.114

.237

.100

-.031

.7

.073

-.200

.114

.253

.107

-.033

.6

.073

-.200

.114

.274

.115

-.036

.5

.073

-.200

.114

.300

.126

-.039

Note. Latency reliability was varied by fixing the error term for the latency
indicator to (one minus reliability) times the variance of the latency indicator.

Model Variants Involving Length of Stay
Two sets of analyses were conducted to examine the effects of length of stay on
study conclusions. First, the Coping and Enhancement RPCO models were re-estimated
using participation indicators computed across the length of stay. Second, length of stay
itself was included to assess effects attributable to treatment duration. Procedures for
examining these supplementary variables included free estimation of paths, as well as a full

67

series of step analyses parallel to those described previously. Results of these analyses
were for all practical purposes identical to the original Coping and Enhancement RPCO
models. Neither participation computed across the length of stay nor length of stay in days
yielded significant paths beyond those present in the trimmed models described in Tables
7, 9, 11 and 13, so these findings are not presented in further detail here.
Model Variants Involving Topic Groups
The final set of supplementary analyses concerned the effects of a secondary
measure of treatment exposure, NTOPIC, the mean number of topic-oriented groups
attended per day during the first week of treatment. As described previously, NTOPIC
embodied a set of optional discussion groups in which highly personalized methods like
role-playing were used to address recovery-related issues. In the supplementary analyses
described here, NTOPIC was added to the two RPCO models using latency as the
outcome measure, creating two risk/topic group/participation/confidence/outcome
(RTPCO) models (one for Coping and one for Enhancement). In addition to the six paths
A through F present in the original RPCO models, the RTPCO models had four new
paths: A' (risk to NTOPIC), B' (NTOPIC to Participation), C' (NTOPIC to confidence),
and E' (NTOPIC to Latency). Goodness-of-fit for the Coping and Enhancement RTPCO
models are presented in Table 18, and the model comparisons constituting path steps are
displayed in Table 19.
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Table 18
Goodness ofFit for RTPCO Models
Path Model
Coping
Uncorrelated baseline
RTPCO, constrained
RTPCO, trimmed
RTPCO, trimmed at 1.64
Enhancement
Uncorrelated baseline

x2

d[_

2

[!_

GFI RMR X ldf NNFI NFI

908.7 55 .000 .442 148.2 16.5
63.1 43 .025 .911 39.6 1.5 .93

IFI

CFI

.91

.98

.93

34.7 41 .747 .946

29.9

.9 .96

.95

1.0

.96

31.7 40 .821 .951

13.9

.8

.97

.95

1.0

.96

839.1

55 .000 .4 59 172. 8 15. 3

R TPCO, constrained

74.6 43 .002 .894

49.5

1.7 .91

.89

.96

.91

R TPCO, trimmed
RTPCO, trimmed at 1.64

48.5 40 .169 .925
45.6 39.218 .929

14.8 1.2 .94
15.3 1.2 .95

.92
.92

.99
.99

.94
.95

Note. A dash ("-") indicates not applicable; GFI = LISREL goodness of fit index;
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and
CFI based on comparison to respective uncorrelated baseline.

Several things should be noted about the RTPCO solutions. First, results of the
step tests for the six original paths (A through F) are almost identical to those derived in
the original latency-based RPCO models (compare to Tables IO and 14). Second, only one
of the four new paths achieved significance at the .05 level (i.e., C', the path predicting
discharge self-efficacy from NTOPIC), and this path was significant for both Coping and
Enhancement. Third, the trimmed Coping model included two significant paths (path C'
and path D, the latter predicting latency from discharge self-efficacy}, while the trimmed
Enhancement model included three (path C', path D, and path B, predicting confidence at
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discharge from risk at baseline). Thus, the resulting trimmed RTPCO models were the
same as the trimmed RPCO models, with the exception of the addition of path C '. Fourth,
the C' path was negative in both solutions, indicating that more exposure to topic groups
served to lower self-efficacy at discharge -

a result opposite in direction to the effect on

self-efficacy predicted for the Participation factor.

Table 19
Path Steps for R TPCO Models
Enhancement

CoEing
Model ComEarison

LR

d[

!!_

LR

df

!!_

Constrained vs. free A

0.15

1

.699

0.49

1

.484

Constrained vs. free A'

0.00

1.00

0.21

1

.647

Constrained vs. free B

2.43

1

.119

3.96

1

.047

Constrained vs. free B'

1.23

1

.267

1.24

1

.265

Constrained vs. free C

1
1

.708
.000

0.97
14.93

1

Constrained vs. free C'

0.14
24.13

1

.325
.000

Constrained vs. free D

4.32

1

.038

5.78

1

.016

Constrained vs. free E

1.15

1

.264

1.15

1

.264

Constrained vs. free E'

0.23

1

.632

0.24

1

.624

0.54
Constrained vs. free F
Trimmed vs. Trimmed at 1.64 2.93

1
1

.462

0.43

1

.512

.087

2.90

1

.089

Note. LR = likelihood ratio test statistic

Finally, an additional modification of the RTPCO models was assessed.
Examination of the t values for path parameters in the fully saturated models supported the
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results of the step tests reported in Table 19, with one exception for each model.
Typically, a critical t of 2 is used to assess parameters for significance: parameters with
cutoff t values of 2 or higher are generally considered significant at the .05 level, and this
means of assessing significance usually converges with the results of the chi-square
difference (LR) tests, as found here. In this case, however, inclusion ofNTOPIC in the
models produced t values above 1.64 (i.e., significance at the .10 level) for one additional
parameter in each model. For Coping, the 1.64 t cutoff also led to significance for the B
path (predicting confidence from risk). For Enhancement, the 1.64 cutoff led to inclusion
of the C path (predicting confidence from Participation). Note that these result are not
reflected by the LR tests of these paths in Table 19, where the steps in which these two
additional paths were freed individually did not produce significant results at the . 10 level
(although the p value for the B path in the Coping RTPCO, .119, is close to this level). It
should also be noted that the marginal level of significance for these two additional paths
was not the case for either of the RPCO models -

in other words, results reported in

Tables 9 and 10 (for Coping) and Tables 13 and 14 (for Enhancement) were the same
whether a t cutoff of 2 or 1. 64 was used.
Since the R TPCO results based on t values and the results based on LR step tests
were divergent, and since the number of subjects available in this study led to relatively
low power to detect effects, both models were re-estimated and examined using the results
based on t values of 1.64. Table 18 lists these results as "RTPCO, trimmed at 1.64," and
the last test shown in Table 19 provides additional comparisons in which the RTPCO
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models with and without the borderline paths are compared. Table 18 shows a very minor
improvement in fit for both models when the questionable paths are included. Table 19
demonstrates that, in both cases, inclusion of these paths yields an improvement over the
trimmed models significant at an alpha level of .10, which converges with the results of the
t

tests for these parameters. Completely standardized parameter estimates for the resulting

R TPCO path models trimmed at 1. 64 are illustrated in Figure 6. Except for the paths
involving NTOPIC, and the two additional paths that achieved significance at .10 when
NTOPIC was included (i.e., path Bin the Coping model and path C in the Enhancement
model), the parameter estimates reported in Figure 3 are very similar to those produced in
the two final trimmed RPCO models (compare to completely standardized betas listed in

Table 15).
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Figure 6
Final RTPCO Path Models With Parameter Estimates
1.0

Coping

Topic
Groups

.771

.201

.960

1.0

Enhancement

Topic
Groups

.782

.229

.948

Note. Circles indicate latent variables, boxes are observed indicators, anchored arrows
represent causal pathways, and unanchored arrows represent error variance. Measurement
parameters are omitted for ease of presentation. All parameters are completely
standardized estimates, significant at p < .10.

CHAPTER6
DISCUSSION
The measurement hypotheses of this study were well supported by confirmatory
factor analyses. The M4 factor structure applied to IDDS and SCQ data yielded excellent
fit when Coping and Enhancement were considered together, as well as when they were
broken into separate models, confirming prior research using these instruments (Parrella,
l 996a, l 996b). The items comprising Participation, too, yielded a single well-fitting factor

as predicted, and this result held for data based on the first week of treatment as well as
for participation data from the entire length of stay. This set of confirmatory factor
analyses provided a solid foundation for considering the structural hypotheses represented
by the path analyses.
Path hypotheses, however, received only limited support. Although the final RPCO
trimmed path models produced good fit, none of the six paths represented in the Coping
RPCO model were significant at either the .05 or the . I 0 level when relapse status was
used as the outcome measure. For the Enhancement RPCO with relapse status, which also
demonstrated good fit, only the B path representing prediction of confidence at discharge
from risk at baseline achieved significance. This lack of evidence of predictive power for
both the Coping and Enhancement RPCO models in regard to relapse status was robust
across the model variants involving length of stay that were considered: neither length of
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stay in days nor participation calculated across length of stay appeared to provide
incremental predictive power with respect to relapse status.
When relapse latency was used as the outcome measure, both the Coping and
Enhancement RPCO models converged with findings from previous research on smoking
cessation treatment. Abstinence self-efficacy at discharge, or confidence, was found to be
the only significant predictor of relapse latency in both cases, accounting for about 4% of
latency variance in the Coping model and about 5% of the variance in the latency measure
in the Enhancement model. In both cases, greater confidence meant longer time to first
use. These results, too, were robust across length of stay model variants, and they held for
the subgroup of individuals who reported use at follow-up as well as for the sample as a

whole (results for those who used mirrored results for the sample as a whole, and so were
not presented here). The power of LR step tests to detect effects in the RPCO models
described in this study was low for the non-significant paths, but the magnitude of the
coefficients for these paths solutions -

as represented by estimated parameters in the unconstrained

suggested that such effects would have accounted for only about I% of the

variance in the respective criterion variables, and so would not have been particularly
meaningful even if they had attained statistical significance.
Nevertheless, failure to find significant effects of participation in the RPCO models
raises questions about the conceptualization of participation used in this study. Although
motivation and participation are not the same thing, they are clearly related, so an inability
to demonstrate participation effects reinforces Miller's (1985) contention that it can be
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difficult to operationalize patient motivation adequately. One possibility is that TPS
volunteers who were involved enough in the study to provide data at all four points of
data collection (i.e., at baseline, during treatment, at discharge, and at the six-month
follow-up) represent a subset of compliant individuals, producing a restriction of range for
participation that lowered correlations with other measures. The participation items,
however, were normally distributed, lacking either skewness or excessive kurtosis, and
this argues against restriction of range due to volunteer status. Another possibility is that
the stochastic exposure assumption was faulty- i.e., the assumption that more
participation implies more exposure to the sources of self-efficacy information (i.e.,
visceral experience, vicarious information, verbal persuasion, and performance) identified
by Bandura (1977). Correlations of performance items with other workbook measures,
however, argue against this interpretation as well. Participation was inversely related to
self-reported craving and negative mood in the TPS, and it was positively correlated with
the perceived helpfulness of other patients, perceived program impact, and perceived
results at discharge. Other correlational analyses demonstrated significant associations
between participation and both patient and therapist ratings of patient motivation at
baseline (cf, Parrella et al., 1993). Furthermore, a previous investigation using this index
showed that both general self-efficacy and positive outcome expectations of treatment at
baseline predicted a significant proportion of participation variance (Parrella, 1995).
Of course failure to reject the null hypothesis that participation didn't have
significant effects in RPCO models doesn't prove this to be the case. Yet the general
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nature of the participation measure used here doesn't take into account potentially
significant confounds. Patients may not have felt that program materials made sense or
applied to them, or they may have participated from the perspective of critic, selectively
seeking attitudinally-congruent information. Nor does the notion of perceived participation
control for variation that may be attributable to differential anchors for the referents
embodied in the items - for instance, objectively similar levels of effort or contribution
may have been perceived and rated differently depending on factors such as extroversion
or social anxiety. In other words, the meaning of participation may have varied depending
on a number of circumstances. It is not clear, for example, that making several comments
on other people's problems during many group sessions necessarily implies more exposure

to self-efficacy information than would a single difficult admission over the course of an
entire treatment episode. If the question comes down to "Who needs what?" a global
index of overall participation may not be specific enough to address the idea that some
patients need sensitization or motivation to change while others who are already motivated
need training in skills like controlling anger or managing anxiety. A more compelling test
of study hypotheses, then, would probably require less global and less subjective measures
of exposure to a wider variety of potentially important treatment components.
Having said that, supplementary analyses in which a dose measure of topic groups
was introduced produced additional findings that also may help to explain these results.
Both the Coping and Enhancement R TPCO models showed statistically significant paths
from topic group dose to discharge self-efficacy. The coefficients for these paths were
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negative, indicating that more exposure to topic groups tended to produce lower
abstinence self-efficacy. Although this result may at first seem counter-intuitive, MMCD
treatment is based on a disease model of alcoholism, and the disease model -

with its

focus on loss-of-control drinking and the unalterable nature of alcoholism -

stresses the

fragile nature of recovery, as exemplified by slogans such as "one day at a time." This
philosophical framework implies that abstinence self-efficacy, or confidence, is anathema
to the ongoing process of maintaining abstinence, and a treatment approach emphasizing
that viewpoint is consistent with the topic group results found here.
Inclusion of the topic groups measure also led to a borderline level of statistical
significance for the path predicting self-efficacy from participation in the Enhancement
model, a predicted effect that was opposite in direction to the effect of topic groups.
These findings suggest that MMCD treatment may produce competing effects on selfefficacy at discharge, providing support for the contentions of Marlatt (1985) and Rollnick
and Heather (1982) that the disease model loss-of-control tenet embodied in MMCD
treatment may in fact serve to reduce the likelihood of subsequent abstinence. Simply
adding the opposing indirect effects on latency of topic groups and perceived participation
in the Enhancement model demonstrates how the net decrease in latency serves to obscure
the somewhat smaller but nonetheless positive contribution of patient participation.
These results support the idea that abstinence self-efficacy predicts relapse latency,
as Bandura's (1977, 1986) self-efficacy theory would suggest. The absence of direct paths
to latency from topic groups and participation also indicates that the competing effects on
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latency attributable to these two variables in the Enhancement RTPCO were completely
mediated by self-efficacy at discharge. That finding further reinforces the intent behind this
study, to assess MMCD treatment using self-efficacy as a common metric to examine
treatment effects. Moreover, although a lack of overall effects for MMCD treatment
programs has often been attributed to the "washing out" of differential treatment
effectiveness for different patients that results from considering only the main effects of
treatment, the R TPCO findings reported here point to a somewhat different aspect of this
issue: the possibility that a lack of overall effects may be due in part to opposing effects of
different components or facets of the treatment experience. This interpretation
underscores the value of process analysis, and it emphasizes the importance of attempts to
isolate the "active ingredients" ofMMCD treatment for detailed study.
Limitations. Several limitations of this study should be acknowledged. Because this
was a naturalistic observational study based on correlational analysis of self-report data,
rather than a controlled experiment in which variables were manipulated and observed
more objectively, it would be inappropriate to draw unequivocal conclusions on the basis
of the results reported here. The longitudinal nature of data collection obviates some of
the more egregious concerns plaguing causal interpretations of cross-sectional data,
making it implausible, for example, that latency caused abstinence self-efficacy, or that
participation caused risk. The results reported here do not, however, speak to issues like
reciprocal causation, the validity of self-reports, or third-variable interpretations. It may
well be, for instance, that risk and participation are reciprocally related across multiple
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panels, or that some common unmeasured factor such as social desirability influenced
reports of both abstinence self-efficacy and relapse latency. This research was not
designed to address such questions, although the sensitivity analysis conducted for relapse
latency suggests that inclusion of additional indicators that increase the reliability of the
latency measurement would accentuate the effects described here. Additional studies in
which potential confounds like these are specified and explored would be required to rule
out such threats to validity.
With regard to measurement issues, although most of the indicators used here
showed excellent distributional properties, the SCQ scales evidenced some degree of both
kurtosis and restriction of range. While models involving these indicators fit the data well
and converged with results from other samples, kurtosis may have affected results in some
way not immediately apparent. The degree of model fit, and the fact that the effect of
abstinence self-efficacy on relapse latency was the only one to reach significance in RPCO
models, suggest that this was not a serious problem. It should be noted, however, that the
restricted range of SCQ scales probably attenuated correlations, biasing results in a
conservative direction. This, along with latency unreliability, less-than-perfect self-report
reliability, and the importance of post-discharge factors noted by other investigators (cf,
Moos et al., 1990), undoubtedly contributed to the inability of self-efficacy to account for
more than a small percentage of the variance in relapse latency.
The use of abstinence status, a dichotomous categorical indicator, as an outcome
measure, however, directly violates the normality assumptions of covariance structure
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analysis. Maximum likelihood estimation is in general considered relatively robust to
violations of these assumptions, and the use of dichotomous indicators in covariance
structure models is not unprecedented, being analogous to dummy coding in standard
regression analyses (see, for example, Hayduk, 1987, who illustrates this with several
models incorporating categorical indicators). Bollen (1989) cites robustness studies
suggesting that it is excessive kurtosis, rather than the number of categories, that may
create problems in covariance structure models with categorical variables, producing
inflated chi-square values and standard errors. Examination of the solutions involving
relapse status in this sample shows chi-square values and standard errors comparable in
magnitude to those obtained from the continuous latency measure. Nevertheless, the
relapse status results reported here should be interpreted cautiously, especially given the
absence of significant effects for the predictive paths tested in status-based models.
Another important issue involves sample size and the criteria used to assess
statistical significance. In this study, a relatively small number of subjects provided data
from all four instruments, resulting in low power to detect small effect sizes. This situation
was complicated by the opposing implications of the alpha cutoff for the LR statistic and
the chi-square test of overall model fit, which can make choosing a single level of
significance problematic. If alpha is lowered to prevent capitalization on chance in the LR
tests, models that provide less fit will be accepted using this alpha value as a decision
criterion for the chi-square test. If alpha is raised to make the chi-square test more
stringent, this relaxes the criterion for LR tests. Furthermore, as noted by Bollen (1989),
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when repeated tests are performed on the same data, as when comparing different models,
the resulting chi-square test statistics are correlated, and the usual probability levels do not
reflect this lack of independence. For these reasons, all results were considered at
traditionally-accepted alpha levels of both .05 and .10, and adjunctive fit indices were
used, but no correction for the number of tests conducted in this study was performed.
Consequently, cross-validation of the findings reported here assumes added importance.
Future directions. A number of directions for future research are indicated. Given
the possibility of competing effects for different elements ofMMCD treatment, it is
important to try to operationalize these elements using more objective measures. For
example, structured inventories with behavior-based response options might help to

address the subjective nature of the participation index, whereas a voucher system might
enable tracking of service component delivery. Multiple sources of participation data (e.g.,
including participation ratings from therapists as well as patients) could be used to address
this issue. A series of measures specifically designed to tap Bandura' s ( 1977) four sources
of self-efficacy information seems the next logical step.
Given that a significant contribution of pre-existing outcome expectations to
subsequent treatment participation has been demonstrated (cf, Parrella, 1995), outcome
expectations and other patient characteristics such as psychiatric comorbidity would be
important additions in further tests of the model. The results of this study should be crossvalidated on other samples, with larger numbers of subjects, and it would be interesting to
see if findings vary by substance type, as previous work (e.g., Filstead, Parrella, & Ebbitt,
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1988; Ross, Filstead, Parrella, & Rossi, 1994) has shown both commonalities and
differences in the hierarchy of risk situations across substances of primary abuse. Therapist
characteristics, too, have been associated with the differential treatment success of clients
(e.g., McLellan, Woody, Luborsky, & Goehl, 1988), and since different facilities introduce
both unique as well as programmatic variance, a multi-site replication in which both
program and therapist characteristics are incorporated would allow specific tests of these
factors.
Summary. Although the small sample size raised some questions about the power
of statistical tests to detect small effect sizes, the present investigation demonstrated that
abstinence self-efficacy at discharge from MMCD treatment predicted subsequent relapse
latency, converging with similar findings from research on smoking cessation treatment.
Process analyses based on covariance structure modeling revealed significant influences on
self-efficacy for both a general measure of treatment participation and for a more specific
dose-related measure of treatment exposure, suggesting that different aspects of the
treatment program may have exerted competing effects on self-efficacy and, consequently,
produced opposing indirect effects on relapse latency. These results support the use of
self-efficacy as a common metric for examining addiction treatment based on disease
model principles, and they emphasize the importance of process analysis as a mechanism
for identifying and assessing the "active ingredients" of MMCD programs.

APPENDIX
Following is the PREUS code used to generate the covariance matrices used in
the RPCO models, along with output comprising the resulting covariance matrices and
univariate and multivariate descriptive statistics for the observed indicators. Also included
are the USREL commands used to specify the three RPCO models in Tables 9 and 13
(i.e., the uncorrelated baseline, fully constrained, and final trimmed models). PREUS and
USREL commands are listed separately for the Coping and Enhancement RPCO models.
Note that the order of variables here differs from the order of presentation of the zeroorder correlations in Table 3.
Coping
subtitle 'RPCO, generate Coping covariance matrix'.
prelis
/variables= RNES RIPC RNPS PEFFORT PMOTIVN PCONTRB
CNES CIPC CNPS TTFUPCT (CO)
/missing=listwise exclude /type=covariance
/print=kurtosis /matrix=out (*).
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TOTAL SAMPLE SIZE

=

109

UNIVARIATE SUMMARY STATISTICS FOR CONTINUOUS VARIABLES
VARIABLE

MEAN

ST. DEV.

SKEWNESS

KURTOSIS

RNES
RIPC
RNPS
PEFFORT
PMOTIVN
PCONTRB
CNES
CIPC
CNPS
TT FU PCT

S0.890
39.661
36.477
4.461
4.641
4.4S3
77.804
81.449
83.613
76.987

27.810
27.lSO
2S.943
.767
.7SS
.847
18.991
18. 321
18. 399
36.413

-.lSO
.349
.432
-.S20
-.281
-.407
-. 713
-1.121
-1.172
-1.2S3

-.967
-.714
-.707
-.006
-.484
-.307
-.442
1.124
.782
-.100

RELATIVE MULTIVARIATE KURTOSIS

=

MINIMUM FREQ.
.000
.000
.000
2.300
2.700
2.200
30.000
11.000
18.000
.000

6
10
7
1
1
1
1
1
1
7

MAXIMUM FREQ.
100.000
100.000
100.000
6.000
6.000
6.000
100.000
100.000
100.000
100.000

.113 7140+01

COVARIANCE MATRIX

RNES
RIPC
RNPS
PEFFORT
PMOTIVN
PCONTRB
CNES
CIPC
CNPS
TT FU PCT

RNES

RIPC

RNPS

PEFFORT

773. 39S
67S.842
S74.294
.277
-2.836
-.474
-82.489
-73.820
-27.251
-89. 392

737.llS
S30.423
-.044
-3.026
-.988
-77.064
-90.046
-30.694
-27. S77

673.030
.374
-1. 746
.830
-94.S76
-10S.1S6
-112.196
-S.464

.770
.473
.770
2.426

.S88
.423

.sos

COVARIANCE MATRIX

CNES
CIPC
CNPS
TT FU PCT

CNES

CIPC

CNPS

TT FU PCT

360.6S4
316.989
287.968
113.4Sl

33S.664
288.900
133 .036

338. S28
117.744

132S.932

subtitle 'RPCO, Coping only, uncorrelated baseline'.
lisrel
l"RPCO, Coping only, uncorrelated baseline"
Ida ni=IO
Imo nx= I 0 nk= I 0 lx=id td=ze ph=di
lou sc.

PMOTIVN

PCONTRB

.S69
.4S7
.214
.093
-.184
3.1S3

.717
.798
.611
.429
2.73S

2
3
1
1
2
2
11
21
30
70
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subtitle 'RPCO, Coping only, constrained'.
lisrel
/"RPCO, Coping only, constrained"
/da ni=IO
Imo ny= I 0 ne=4 te=sy,fi be=sd ps=fi
/fi ly I I ly 4 2 ly 7 3 ly 10 4
/va I ly I I ly 4 2 ly 7 3 ly I 0 4
/fr ly 2 I ly 3 I ly 5 2 ly 6 2 ly 8 3 ly 9 3
/fr te I I te 2 2 te 3 3 te 4 4 te 5 5 te 6 6 te 7 7 te 8 8 te 9 9
/fr te I 7 te 2 8 te 3 9
/fr ps I I ps 2 2 ps 3 3 ps 4 4
/fi be 2 I be 3 I be 3 2 be 4 I be 4 2 be 4 3
/va 0 be 2 I be 3 I be 3 2 be 4 I be 4 2 be 4 3
/le
/coprisk partic copconf latency
Jou ad=off it=500 sc se tv.

subtitle 'RPCO, Coping only, trimmed'.
lisrel
/"RPCO, Coping only, trimmed"
/da ni=IO
Imo ny= I 0 ne=4 te=sy,fi be=sd ps=fi
/fi ly I I ly 4 2 ly 7 3 ly I 0 4
/va I ly I I ly 4 2 ly 7 3 ly I 0 4
/fr ly 2 I ly 3 I ly 5 2 ly 6 2 ly 8 3 ly 9 3
/fr te I I te 2 2 te 3 3 te 4 4 te 5 5 te 6 6 te 7 7 te 8 8 te 9 9
/fr te I 7 te 2 8 te 3 9
/fr ps I I ps 2 2 ps 3 3 ps 4 4
/fi be 2 I be 3 I be 3 2 be 4 I be 4 2
/va 0 be 2 I be 3 I be 3 2 be 4 I be 4 2
/le
/coprisk partic copconf latency
Jou ad=off it=500 sc se tv.
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Enhancement
subtitle 'RPCO, generate Enhancement covariance matrix'.
prelis
/variables= RPSS RSP RPES PEFFORT PMOTIVN PCONTRB
CPSS CSP CPES TTFUPCT (CO)
/missing=listwise exclude /type=covariance
/print=kurtosis /matrix=out (*).
TOTAL SAMPLE SIZE =

109

UNIVARIATE SUMMARY STATISTICS FOR CONTINUOUS VARIABLES
VARIABLE

MEAN

ST. DEV.

SKEWNESS

KURTOSIS

RPSS
RSP
RPES
PEFFORT
PMOTIVN
PCONTRB
CPSS
CSP
CPES
TT FU PCT

51. 266
50.092
49.587
4.461
4.641
4.453
82.667
79.170
84.618
76.987

30.551
30.539
27.798
.767
.755
.847
19.225
22.666
18.975
36.413

-.267
-.204
-.221
-.520
-.281
-.407
-1. 066
-1. 062
-1.158
-1.253

-1.143
-1.077
-.846
-.006
-.484
-.307
.110
.427
.381
-.100

RELATIVE MULTIVARIATE KURTOSIS

=

MINIMUM FREQ.
.000
.000
.000
2.300
2.700
2.200
32.000
6.000
25 .000
.000

10
11
11
1
1
1
1
1
1
7

MAXIMUM FREQ.
100.000
100.000
100.000
6.000
6.000
6.000
100.000
100.000
100.000
100.000

.1110250+01

COVARIANCE MATRIX
RSP

RPES

PEFFORT

PMOTIVN

PCONTRB

932.621
590.038
2.734
-1. 016
2.248
-101.148
-186.586
-46.014
-94.462

772.745
-2.354
-4.540
-2.874
-93.076
-100.500
-72.844
-73.725

.588
.423
.505
1.054
.305
2.519
2.426

.569
.457
1. 359
.841
1. 347
3.153

.717
1.718
1.853
3.093
2.735

RPSS
RPSS
RSP
RPES
PEFFORT
PMOTIVN
PCONTRB
CPSS
CSP
CPES
TT FU PCT

933. 382
854.290
624.231
2.502
- . 535

1.624
-104.465
-148.701
-51.086
-64.561

COVARIANCE MATRIX

CPSS
CSP
CPES
TT FU PCT

CPSS

CSP

CPES

TT FU PCT

369.614
364.167
313.591
161.189

513.764
304.989
116.527

360.063
117.601

1325.932

2
3
4

1
2
2

28
28
45
70
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subtitle 'RPCO, Enhancement only, uncorrelated baseline'.
lisrel
/"RPCO, Enhancement only, uncorrelated baseline"
/da ni=IO
Imo nx= I 0 nk= I 0 lx=id td=ze ph=di
/ou sc.
subtitle 'RPCO, Enhancement only, constrained'.
lisrel
/"RPCO, Enhancement only, constrained"
/da ni=IO
Imo ny= I 0 ne=4 te=sy,fi be=sd ps=fi
/fi ly I I ly 4 2 ly 7 3 ly I 0 4
/va I ly I I ly 4 2 ly 7 3 ly I 0 4
/fr ly 2 I ly 3 I ly 5 2 ly 6 2 ly 8 3 ly 9 3
/fr te 2 2 te 3 3 te 4 4 te 5 5 te 6 6 te 8 8 te 9 9
/fr te 2 3 te 8 9 te I 7 te 2 8 te 3 9
/fr ps I I ps 2 2 ps 3 3 ps 4 4
/fi be 2 I be 3 I be 3 2 be 4 I be 4 2 be 4 3
/va 0 be 2 I be 3 I be 3 2 be 4 I be 4 2 be 4 3
/le
/enhrisk partic enhconflatency
/ou ad=off it=SOO sc se tv.
subtitle 'RPCO, Enhancement only, trimmed'.
lisrel
/"RPCO, Enhancement only, trimmed"
/da ni=IO
Imo ny=IO ne=4 te=sy,fi be=sd ps=fi
/fi ly I I ly 4 2 ly 7 3 ly 10 4
/va I ly I I ly 4 2 ly 7 3 ly I 0 4
/fr ly 2 I ly 3 I ly 5 2 ly 6 2 ly 8 3 ly 9 3
/fr te 2 2 te 3 3 te 4 4 te 5 5 te 6 6 te 8 8 te 9 9
/fr te 2 3 te 8 9 te I 7 te 2 8 te 3 9
/fr ps I I ps 2 2 ps 3 3 ps 4 4
/fi be 2 I be 3 2 be 4 I be 4 2
/va 0 be 2 I be 3 2 be 4 I be 4 2
/le
/enhrisk partic enhconf latency
/ou ad=off it=SOO sc se tv.
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